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  7 Introduction 
1. Introduction 
Transdisciplinarity, that is, the integration of different academic disciplines, has been of 
exceptional value for the scientific investigation of complex phenomena. On a small scale, 
the advantageous confluence of experimental and correlational psychology being observed 
by Cronbach (1975) has been a prominent example of such a transdisciplinarity, but also 
large scale approaches have been fostered successfully (e.g., by the international HapMap 
project, Gibbs et al., 2003; that integrated expertise from molecular genetics, medicine and 
bioinformatics). However, the effective implementation of technologies that originated 
from highly specialized branches of science also requires the willingness to efficiently 
exchange methodological knowledge in order to transcend the possibilities of isolated 
scientific domains (cf. Youngblood, 2007). This statement applies particularly to the field 
of psychoneuroendocrinology, which is concerned with the investigation of interactions 
between psychological, neural, and endocrine processes. 
Physiological correlates of psychological stress, particularly, the hypothalamic-pituitary-
adrenal (HPA) and the sympathetic nervous system (SNS) activity, have been among the 
most extensively studies constructs in psychoneuroendocrinology. This was at least 
because both have been related to a large variety of psychosocial phenomena and 
psychopathological disorders (e.g., Burke, Davis, Otte, & Mohr, 2005; Dawans, 
Fischbacher, Kirschbaum, Fehr, & Heinrichs, 2012; Häusser, Kattenstroth, van Dick, & 
Mojzisch, 2012; Morris, Compas, & Garber, 2012; Schumacher, Kirschbaum, Fydrich, & 
Ströhle, 2013). Stress research has become increasingly popular during the last 20 years 
due to huge methodological advances, which mostly relate to the availability of cost-
efficient and convenient biochemical assays that enabled easy acquisition of endocrine 
data (see Kirschbaum & Hellhammer, 1989; 1994; Nater & Rohleder, 2009). Although 
most subsequently published stress study results were only achievable due to the reliance 
on such assays and the corresponding knowledge incorporation on a rather conceptual 
level, the actual integration of methodological expertise from all involved scientific 
disciplines seems to have been only of marginal interest. While this may have been partly 
due to infrastructural issues (i.e., the establishment biochemical laboratories is expensive 
and requires a certain occupancy rate before amortization is reached), the presumed major 
reason might be much simpler: Due to growing specialization, modern academic 
curriculae are sparsely interconnected (Russell, 2002, pp. 20-23). Psychologists are mainly 
concerned with the assessment of psychological constructs and endocrinologists put 
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emphasis on the kinetics and dynamics of hormonal systems. Both disciplines tend to 
regard assay technology as a tool, whereas analytical chemists are mainly concerned with 
the tool itself. 
Nonetheless, all of the above mentioned domains can be considered as instances of the 
same scientific paradigm – construct measurement and effect quantification – that is, they 
are supposed to be commensurable (see Kuhn, 2012). Irrespective of hormone 
concentrations being determined, hormone secretion and elimination being assessed or 
stress outcomes being investigated; the key methodology always involves specification of 
a statistical model, that relates the obtained data to some abstract, latent entities. Such 
statistical models are parsimonious formalizations of substantive stress-relevant theory, 
and are therefore prone to oversimplification. Although specification of simple models 
might be of particular importance for the communication of results in modern, 
multidisciplinary stress research, one might nonetheless ask if current modeling habits 
achieve this goal at the expense of the specific methodological knowledge, which is 
necessary in order to prevent the publication of biased findings. George Box has boiled 
this issue down to an essence: “Remember, all models are wrong; the practical question is, 
how wrong do they have to be not to be useful” (Box & Draper, 1987, p.74). 
Addressing this question shall be major objective of the present thesis, by illustrating, that 
insufficient consideration of auxiliary hypotheses and confounds regarding the 
measurement and quantification of stress may obscure and in some cases even hinder the 
detection of substantial effects. Although this thesis focuses on the inference on HPA 
activity in particular, most of the brought-up topics apply to the investigation of other 
endocrine systems as well. In order to provide practical guidelines for improving the 
quantification of HPA activity, hormone measurement and modeling issues are discussed, 
and readily accessible solutions to these issues are provided. By doing so, the present 
thesis aims to contribute to bridging the gap between psychobiology and “foreign” 
methodology, in order to facilitate knowledge exchange across all involved academic 
disciplines, and thus to improve the quality of future stress research. 
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2. The hypothalamus-pituitary-adrenal (HPA) axis 
2.1 HPA axis structure and its physiological properties 
In psychobiological stress research, the hormone cortisol is supposed to be the most 
popular biomarker for the assessment of HPA activity, which highlights the need for a fair 
amount of physiological knowledge about the hormone dynamics in general, and cortisol 
secretion in particular. While the inclined reader shall be referred to Paschke and Voigt 
(2010) for a more holistic discussion of the HPA axis (and its relation to other endocrine 
systems), the present chapter sets out provide the communicative basis for the discussion 
of cortisol-based HPA activity quantification. 
Similar to most other mammalian endocrine systems, the HPA axis is characterized by a 
complex, dynamic interaction of its components, and can therefore be regarded as a 
prototypical example of endocrine functioning. As can be deduced from its name, the 
HPA axis includes three major physiological components: (a) the hypothalamus, (b) the 
pituitary gland (specifically, its anterior part; the so-called adenohypophysis), and (c) the 
adrenal glands. The interaction of these three components relies on signal transmission by 
chemical messengers in-between them. These chemical messenger molecules are called 
hormones and are synthesized within specific cells of the system’s components, before 
they are released into and distributed by the blood stream, in order to unfold some impact 
at proximate and distant target sites. Such target sites are formed by any cell tissue that 
expresses receptor molecules for these hormones, including the system’s remaining 
components, which may in turn respond by releasing other hormones (i.e., feed-forward 
loops) or inhibition of further secretagogue1 release (i.e., feedback loops). In consequence, 
a complex signal cascade is established.  
With regard to HPA activity as indicated by cortisol, such a signal cascade “starts” by the 
secretion of corticotropin-releasing hormone (CRH) from the hypothalamic 
neurosecretory cells of the nucleus paraventricularis into the portal blood of the 
                                                
1 Secretagogues are substances that cause the release of other substances. 
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adenohypophysis. On site, CRH stimulates the release of corticotrophin (ACTH)2, which 
in turn stimulates (with a certain delay due to ACTH distribution by the blood) the 
synthesis and secretion of cortisol by the cortex of the adrenal glands. Finally, cortisol 
inhibits any further release of CRH from hypothalamic neurosecretory cells and the 
release of ACTH by anterior pituitary corticotrophs. This signal cascade is illustrated in 
Figure 1. 
 
Figure 1. Schematically depicted cascade of HPA axis activity. Secretion of corticotrophin-releasing 
hormones (CRH) from hypothalamic neurosecretory cells stimulates (+) the release of corticotrophin 
(ACTH) by anterior pituitary corticotrophs into the blood stream. ACTH stimulates (+) the synthesis 
and secretion of cortisol by the cortex of the adrenal glands. Conversely, cortisol inhibits (-) the 
release of CRH and ACTH. [Figure components have been obtained from Bear et al., 2008.] 
The outlined interplay between HPA axis components by feed-forward and feedback 
mechanisms, gives rise to the systemic self-regulation of the HPA axis that is supposed to 
                                                
2 Arginine-vasopressin (AVP), which is also released from the hypothalamus, is another secretagogue for 
ACTH. AVP, however, shall not be discussed any further within this thesis, as it is mostly associated 
with chronic and immunological stress (Lightman, 2008). 
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provide the organism with the capability of adapting to environmental requirements; the 
so-called principle of allostasis (see Lightman & Conway-Campbell, 2010). For example, 
the experience of acute psychosocial stress is known to alter the allostatic load of the HPA 
axis and thus to change its activity level (Dickerson & Kemeny, 2004). In absence of any 
change in allostatic load, however, the HPA axis is supposed to converge towards some 
equilibrated activity level (i.e., CRH, ACTH and cortisol levels do not oscillate anymore, 
cf. Urquhart & Li, 1969), which is illustrated in Figure 2. Such a convergence would 
definitely occur, unless any of its components was repeatedly stimulated by well-
documented pacemakers (or zeitgebers): HPA activity is subject to a pronounced circadian 
rhythm that modulates the extent of HPA hormone secretion (Veldhuis, Iranmanesh, 
Johnson, & Lizarralde, 1990) and seems to be driven by the stimulation of the 
hypothalamus by light-responsive neurons of the suprachiasmatic nucleus (Brown, 
Meehan, & Dempster, 2001). As a result, more CRH is secreted as the day begins which 
in turn elevates ACTH and cortisol secretion, and thus shifts the HPA activity equilibrium. 
This shift is manifested by repeatedly occurring ultradian, pulsatile deflections of all 
involved HPA hormone concentrations (Brown et al., 2001; Walker, Terry, & Lightman, 
2010), and consequently establishes the commonly observable oscillatory pattern of HPA 
activity. 
 
Figure 2. An illustrative Lotka-Volterra type model (Volterra, 1926) of HPA activity, given absence of 
any shift of the system’s equilibrium due to pacemakers. Apart from ACTH and cortisol clearance, all 
other parameter values are based on a wild guess. Thus, the concentration of both hormones is 
arbitrarily scaled. 
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Next to the circadian zeitgebers, several environmental setting variables that an individual 
encounters can elicit isolated pulses of HPA activity, and thus temporarily shift the 
activity equilibrium. These variables comprise the above mentioned, randomly 
encountered episodes of acute psychosocial stress (Dickerson & Kemeny, 2004), 
immunological stress after injury or infection, as well as the systematically occurring 
secretory activity of the HPA axis due to daily awakening (Fries, Dettenborn, & 
Kirschbaum, 2009). As the pattern of stress-induced HPA activity seems to contain a 
substantial amount of trait variance (Federenko, Nagamine, Hellhammer, Wadhwa, & 
Wüst, 2004; Kirschbaum, Wüst, Faig, & Hellhammer, 1992b), its investigation in 
laboratory settings has become an important approach to stress research, but the question 
of how to adequately assess and quantify it still remains a subject of debate. 
2.2 Kinetics of HPA hormones in different types of specimen 
Inference on HPA activity relies on the repeated (within-subject) sampling of specimens 
from which the respective indicators of HPA functioning can be obtained. As hormones 
are (by definition) distributed by the blood to unfold effects at their respective target cells 
(Paschke & Voigt, 2010), blood would serve as the presumably most appropriate 
specimen to monitor HPA activity. However, from a practical perspective, several 
physiological characteristics complicate the assessment of HPA activity from blood 
hormone concentrations. 
First, complications arise from the molecular structure of CRH, ACTH and cortisol. CRH 
and ACTH are peptide hormones, that is, they are comparably large, hydrophilic proteins. 
As such, the distribution of both hormones relies on the bloodstream and active cellular 
transport mechanisms. However, blood flow (perfusion) varies across different kinds of 
tissue (e.g., fat is more poorly perfused than muscle tissue), which leads to differential 
hormonal effects at the respective target cells. Cortisol, by contrast, is a small, 
hydrophobic steroid hormone and can thus also be passively distributed by diffusion 
through cell tissue. This structural difference between CRH/ACTH and cortisol is also 
reflected by their respective elimination patterns: While cortisol is eliminated in a 
monoexponential fashion (Perogamvros, Aarons, Miller, Trainer, & Ray, 2011; Tunn, 
Möllmann, Barth, Derendorf, & Krieg, 1992), CRH and ACTH levels have been 
consistently shown to display bi-exponential decay (Liotta, Choh Hao Li, Schussler, & 
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Krieger, 1978; Schürmeyer et al., 1984; Tanaka, Nagata, Itoh, Kumagae, & Shimizu, 
1993) mirroring a perfusion-related dissociation between central and peripheral 
compartments. 
Second, HPA hormones vary substantially in their elimination rate, that is, the velocity at 
which hormones are metabolized and/or excreted from the organism. The mean half-life3 
of CRH in blood (4.1 – 9 min; Schürmeyer et al., 1984; Tanaka et al., 1993) is by far the 
shortest of all HPA hormones, and followed by ACTH, whose mean half-life amounts 
approximately to 15 – 17 min (Liotta et al., 1978; Veldhuis et al., 1990). Considering 
these comparably short hormonal half-lives, blood specimen need to be obtained at high 
frequency and temporally close to HPA stimulation, which might be problematic in case 
the researcher intends to simultaneously assess other (psychological or physiological) 
constructs. Furthermore, most laboratory HPA stimulation protocols barely allow frequent 
blood sampling during protocol completion (see section 3.1). In order to bypass the 
resulting issues with CRH and ACTH concentrations, cortisol determination forms a 
convenient alternative, as cortisol secretion is the last step within the HPA cascade and 
thus exhibits a lagged rise of concentrations (i.e., the cortisol peak occurs 30 - 40 min after 
HPA stimulation; Dickerson & Kemeny, 2004). These temporal dynamics of HPA 
hormones are illustrated in Figure 3. 
 
Figure 3. Transit-compartment differential equation model (Bonate, 2011) illustrating the dynamics of 
HPA hormones after stimulation by bolus CRH administration. The model was informed by the 
pharmacokinetic data from (Schürmeyer et al., 1984). ACTH plasma concentration peaks 9 min after 
challenge whereas cortisol plasma concentration peaks 41 min after challenge. 
                                                
3 The listed half-lives of CRH and ACTH refer to (early) alpha-phase elimination. 
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The half-life of plasma cortisol seems by far the most extended of all primary HPA 
hormones 102 – 128 min (Hiramatsu, 1981; Perogamvros et al., 2011; Tunn et al., 1992), 
although several studies reported shorter half-lives. This is presumably due to variation in 
the methodological approaches: Most pharmacological studies investigate the cortisol 
elimination by suppression of endogenous HPA axis activity via dexamethasone (DEX) 
administration and subsequent bolus intravenous injection of synthetic cortisol or 
ACTH/CRH (e.g., Perogamvros et al., 2011; Tunn et al., 1992). Studies that refrained 
from HPA suppression, estimated substantially shorter blood cortisol half-lives of 66 – 73 
min (Veldhuis, Iranmanesh, Lizarralde, & Johnson, 1989; Weitzman et al., 1971). A 
potential explanation for such divergent cortisol half-lives comes from animal research 
that reported an extraordinarily strong effect of DEX on corticosteroid-binding globulin 
(CBG) mRNA expression, that is, a CBG level reduction to 26% within 72h, as compared 
to other steroids (Smith & Hammond, 1992). Given that high CBG levels have been 
shown to promote cortisol clearance from the blood (Bright, 1995), DEX administration 
would lead to a reduced elimination rate of total cortisol levels. This reasoning is 
consistent with observations of a similarly short cortisol half-life of 61 – 64.5 min when 
the unbound fraction of blood cortisol is separated from CBG- and Albumin-bound 
cortisol by ultrafiltration (Hiramatsu, 1981; Perogamvros et al., 2011). 
In these premises, salivary cortisol levels have been considered valuable, as saliva 
specimen seems to physiologically mimic ultrafiltration of blood (Gröschl, 2008; Vining, 
McGinley, & Symons, 1983). Consistently, half-lives of salivary cortisol range from 41 – 
72 min (Hiramatsu, 1981; Perogamvros et al., 2011; Tunn et al., 1992), and seem to reflect 
unbound cortisol levels (Umeda et al., 1981) with a salivary-to-blood cortisol ratio that 
varies between 18.2% and 2.3% (Tunn et al., 1992). Considering this exceptional feature 
of saliva, one might be inclined to use it as a medium for monitoring HPA hormones in 
general. However, larger peptide hormones require to be actively transferred into saliva 
(Gröschl, 2008), as they cannot diffuse through tissue. Although such transport 
mechanisms have been proposed for e.g. insulin (Fabre et al., 2012), CRH or ACTH are 
barely present in saliva. Finally, the concentration of peptide hormones seems to depend 
on salivary flow rate (Hofman, 2001). In consequence, only salivary cortisol can serve as a 
conveniently obtainable and reliable indicator of HPA activity. Nonetheless, salivary 
cortisol concentrations (SCCs) should be interpreted with caution, as a substantial fraction 
of cortisol might converted to cortisone due to the abundance of the enzyme 11β-
hydroxysteroid dehydrogenase (11β-HSD2) in the parotid glands (Smith et al., 1996). 
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3. Induction and quantification of HPA activity 
3.1 Standardized laboratory protocols 
Although HPA activity is subject to endogenous, phase- and amplitude-shifted 
oscillations, which give rise to the HPA axis’ circadian cycle (see section 2.1), it has also 
been associated with allostatic equilibration processes that are initiated upon the 
experience of acute exogenous strain (Lightman & Conway-Campbell, 2010). This 
circumstance provides researchers with the unique possibility to stimulate the HPA axis 
simultaneously in many subjects and therefore to (partially) synchronize HPA activity 
phases, which greatly facilitates study designs and associated analytical strategies for the 
assessment of HPA activity. According to (Dickerson & Kemeny, 2004), the most 
effective, exogenous stimulation procedures of the HPA axis in humans need to comprise 
the following features: (a) uncontrollability, (b) social-evaluative threat, and (c) effort to 
deal with the encountered situation. Although the latter might mainly associated with the 
SNS-driven stress response (Mason, 1968), effort seems nonetheless a necessary, but no 
sufficient component to elicit HPA axis activity, as both systems interact with each other 
in a time-lagged fashion (e.g., Engert et al., 2011). 
Based on these considerations, many protocols have been proposed to induce stress and 
associated SNS and HPA activity in laboratory settings. The most effective SNS and HPA 
axis challenges have been reported by studies using the Trier Social Stress Test (TSST, 
Kirschbaum, Pirke, & Hellhammer, 1993; see Dickerson & Kemeny, 2004), which 
consists essentially of a mock job interview and a mental arithmetic task in front of an 
evaluating, two-person committee and a recording camera. 
This protocol design, however, requires a considerable amount of personnel resources, and 
consequently various modifications have been proposed (e.g., the Groningen Social Stress 
Test, GSST, Bouma, Riese, Ormel, Verhulst, & Oldehinkel, 2009, which only involves a 
recording camera, or virtual reality-based adaptations, Jönsson et al., 2010) in order to 
enhance the TSST’s efficiency. Apart from some exceptions (e.g., the TSST-G, Dawans, 
Kirschbaum, & Heinrichs, 2011; a protocol allowing to induce HPA activity 
simultaneously in up to six subjects), most of these adaptations have however not been as 
successful as expected, that is, the gain in efficiency went along with a reduced 
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effectiveness of the respective protocols (see Foley & Kirschbaum, 2010 for an overview). 
Conversely, protocols that rely primarily on physiological strain as a stressor (e.g., the 
cold pressor test, CPT, McRae et al., 2006) were as well suited to elicit SNS activity, but 
less effective with regard to HPA axis stimulation. Such protocols benefit significantly 
from the incorporation of social-evaluative components (SECPT, Schwabe, Haddad, & 
Schachinger, 2008). Recently, a new protocol has been proposed, the Maastricht Acute 
Stress Test (MAST, Smeets et al., 2012), which combines components of the SECPT with 
the mental arithmetic task of the TSST. Although its usefulness in research practice 
remains to be confirmed, yet, first results are promising as the MAST has been reported to 
perform comparable to the TSST with regard to both, SNS and HPA stimulation. 
For the purpose of completeness, however, it should be mentioned, that the overall 
effectiveness of any HPA stimulation depends also on many other situational 
characteristics such as the state of the organism prior to strain experience. For instance, 
elevated glucose levels by previous administration of grape juice or cigarette smoking 
may enhance HPA activity (Kirschbaum et al., 1997). Specific setting properties, such as 
spatial narrowness of the stressful environment (which is particularly important for MRI 
studies, Muehlhan, Lueken, Wittchen, & Kirschbaum, 2011) may further alter HPA 
activity. Consequently, such confounds should be taken into account in order to evaluate 
the effectiveness of the implementation of core stress-inducing components in any HPA 
stimulation protocol appropriately. 
3.2 Biochemical determination of salivary cortisol concentrations (SCCs) 
In the field of analytical chemistry, the term specimen is used to refer to any sample of a 
chemical compound, which is to be analyzed. Such specimens contain a certain amount of 
HPA-activity-indicating hormone (i.e., the analyte), which is to be quantified by some 
measurement system. The remains of the specimen form the so-called matrix, which can 
in turn influence the measurement of the analyte. 
As has been extensively discussed in section 2.2, the assessment of HPA activity rests on 
the kinetics of the indicative hormone. Due to its properties, salivary cortisol in particular 
has been proposed as a suitable indicator of HPA activity, as it seems to mirror the 
bioactive fraction of total blood cortisol. Furthermore saliva sampling bypasses the need 
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for venipuncture, which is itself aversive and may (irrespective of psychosocial stress) 
induce HPA activity in some participants (Kirschbaum & Hellhammer, 1989). Thus saliva 
represents to date the most popular specimen for investigating the HPA axis in 
psychobiological stress research (Kirschbaum & Hellhammer, 1989; 2007), although 
cortisol-to-cortisone conversion within the salivary glands by the enzyme 11β-
hydroxysteroid-dehydrogenase has been suggested to restrict the value of saliva specimen 
(Miller, Plessow, Rauh, Gröschl, & Kirschbaum, 2013; Perogamvros, Ray, & Trainer, 
2012). Apart from such theoretical considerations relating to the choice of specimen and 
analyte, a major practical issue with the assessment of HPA activity relates to the choice 
of the measurement system by which the analyte’s concentration within a specimen is to 
be determined. 
Nowadays, the most extensively used biochemical measurement systems involve either 
the immunoassay (IA) principle or the separation of specimen components by 
chromatography and subsequent analyte quantification by mass-spectrometry (MS)4. 
Proceeding from the immunological principle that different biological antigens form 
complexes with their respective antibodies, IA methods rely on specifically raised 
antibodies that selectively bind the analyte. MS methods, on the other hand, rely on 
chemical ionization of specimen compounds in order to generate ionized molecules or 
molecular fragments, which can in turn be related to their respective precursor molecules 
by determining their mass-to-charge ratio. Although both approaches differ substantially 
and therefore entail specific advantages and disadvantages (see Table 1), the actual 
quantification of the analyte rests in both cases on the concurrent availability of a known 
amount of a structurally-related, tagged analyte analogue. 
Table 1. Rank order of the respective assay principle with regard to various criteria. 
Assay-principle Cost Sensitivity Specificity Range Accuracy Time 
IA 1 1.5 2 2 2 1 
MS 2 1.5 1 1 1 2 
With IA methods, such a tagged analyte competes with the untagged analyte being 
contained in the specimen for available binding sites. Subsequently, all unbound analytes 
are removed, and the tag (e.g., a radioactive or a chemiluminescent molecule) is supposed 
                                                
4 As a detailed review of both principles is beyond the scope of the present thesis, the reader shall be referred 
to Wild (2013), and Mondello (2011)/Dass (2007), who provide an in-depth discussion of immunological 
and chromatography/mass-spectrometry-based assays.  
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to serve as a tracer, which generates a nonlinearly weaker signal, the larger the amount of 
the untagged analyte has been. This signal can be used to infer on the analyte’s 
concentration within the specimen in case a valid reference curve has been established 
(see also section 4.1), but also illustrates, why IA methods lack specificity and accuracy: 
First, matrix components that are structurally related to the analyte (e.g., cortisol versus 
cortisone) also exhibit some affinity to the IA antibodies (although to a smaller extent). 
Second, a valid reference curve has to be obtained in a procedural step that is quite 
separable from the process of actual analyte measurement. Consequently, IA measurement 
results are more likely to be biased. With MS methods, by contrast, analyte tags are used 
for the sole purpose of generating a tracer signal (commonly by using analyte-deuterium 
complexes), that slightly differs from the actual analyte’s signal. As such a tracer signal 
corresponds to a known amount of analyte and supposedly changes linearly with the 
tracer’s concentration, it can be used to directly quantify the amount of analyte within a 
specimen. 
3.3 Statistical methods for SCC analysis 
In order to relate longitudinally measured SCCs to the construct of HPA activity it is 
mandatory to specify an appropriate statistical (measurement) model. Considering that 
hormone levels vary continuously across time due to the inherent properties of the 
respective endocrine system (i.e., endocrine rhythmicity and the hormone elimination), a 
large variety of models have been proposed to infer on the status of the investigated 
system from a limited number of specimens. Such specimens are longitudinally sampled at 
discrete points of time, and generate so-called panel data. According to Voelkle, Oud, 
Davidov, and Schmidt (2012), statistical models for the analysis of panel data can be 
roughly differentiated into models in which time is considered explicitly (being referred to 
as continuous-time models) and models in which time is considered implicitly (being 
referred to as discrete-time models). 
Continuous-time models commonly incorporate estimation of a time-related parameter. In 
the present context, the simplest form of such a model is a linear regression that related 
SCCs at two different points in time t0 and t1 to the time on its original scale (see formula 
I). 
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(I) 𝑆𝐶𝐶(𝑡!, 𝑡!) = 𝑎 ∗ 𝑡𝑖𝑚𝑒 + 𝑐	  
Such a simple model, however, assumes that the change that occurs in between t0 and t1 is 
the same for each time unit, which is quite unrealistic considering the nonlinear kinetics of 
the HPA axis (see chapter 1). In case a third point in time (t2) is added to the present 
example, which deviates from the projected linear trajectory of SCCs across time, one 
could sufficiently account for the mean structure of the data by adding a quadratic term 
(see formula II). This model also implies that the mean change, which occurs in between t0 
and t2, can be perfectly described by the given equation5. 
(II) 𝑆𝐶𝐶(𝑡!, 𝑡!, 𝑡!) = 𝑎 ∗ 𝑡𝑖𝑚𝑒 + 𝑏 ∗ 𝑡𝑖𝑚𝑒! + 𝑐	  
Discrete-time models, by contrast, do not assume a continuous SCC trajectory. Proceeding 
from the examples mentioned above, the simplest model for analyzing panel data of such 
kinds is a conventional analysis of variance (ANOVA). As such an ANOVA also belongs 
to the class of the general linear model (GLM, see Everitt, 2009), its model equation is 
quite similar to the regression models mentioned above, but uses dummy-coded sampling 
times as predictors. Consequently, the equation for the SCC(t0,t1) example is the same as 
in formula I, but different for the SCC(t0,t1,t2) example (cf. formula III). 
(III) 𝑆𝐶𝐶(𝑡!, 𝑡!, 𝑡!) = 𝑎 ∗ 𝑡𝑖𝑚𝑒 𝑡!, 𝑡! +   𝑏 ∗ 𝑡𝑖𝑚𝑒 𝑡!, 𝑡! + 𝑐	  
These outlined examples illustrate, that the distinction between continuous- and discrete-
time models is of a rather conceptual kind, because all examples belong to the same model 
class. Differences between them mostly relate to the coding of time and thus to the 
interpretation of the models’ parameter values. 
From a technical point of view, statistical inference on both, continuous-, and discrete-
time model parameters, relies on the same parametric assumptions (or auxiliary statistical 
hypotheses) about the models’ residuals (Everitt, 2009; Harwell, Rubinstein, Hayes, & 
Olds, 1992). For the outlined examples these are 
(1) normal distribution of SCC residuals at any point of time, 
(2) constant residual variances at any point of time (homoscedasticity), and 
(3) uncorrelated residual variances at all points of time. 
                                                
5 This is due to the circumstance that the number of model parameters  to be estimated (i.e., a, b, c) equals 
the number of data parameters (i.e., the means at each sampling point t0 ,t1, t2) 
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If any of these assumptions is violated (and depending on the optimization criterion), 
parameter estimates will be biased and thus their interpretation will become unreliable. 
Fortunately, GLM-based extensions have been developed, among which mixed-effects (or 
hierarchical linear) modeling (Llabre, Spitzer, Siegel, Saab, & Schneiderman, 2004; 
Raudenbush & Bryk, 2002) is presumably the best known approach6, including the overly 
popular repeated-measures ANOVA. These techniques that can be subsumed in the class 
of moment structure analyses, which allow to relax (or at least alter) most GLM 
assumptions. However, the more complex moment structure modeling techniques require 
“result communication templates” that deviate from the familiar GLM standards. 
Furthermore, their implementation can be quite difficult and therefore often requires a 
particular set of non-trivial technical skills, which go beyond the ready-to-use solutions 
provided by most GUI7-based statistical software packages (e.g., SPSS). This applies in 
particular to complex continuous-time models (Bonate, 2011). 
From a content perspective, however, continuous-time modeling yields a major advantage 
as compared to discrete-time modeling of SCC time series: Given an adequate theoretical 
foundation, they enable a more precise prediction of HPA activity at any point in time, 
which is formed by occasional (or forced) pulsatile deflections and concurrent SCC 
elimination. By contrast, HPA activity parameters that have been obtained by discrete-
time models can only be used to infer on HPA activity at the time of sampling, which 
restricts their comparability with the results of other studies for the benefit of an easier 
usability. The specifics of both concepts with regard to HPA activity measurement shall 
be discussed hereafter. 
3.3.1 Continuous-time modeling 
Any statistical model for SCC time series relies on appropriate theoretical assumptions on 
the construct being investigated. In the most basic, rather data-driven case, HPA activity 
can be conceptualized as change of SCCs [ΔSCC(ti) = SCC(ti) – SCC(ti-1)] that occurs in-
between two points in time ti and ti-1, at which specimens have been sampled. Change 
scores can serve as a convenient indicator of endocrine activity (e.g., Linden, Earle, Gerin, 
& Christenfeld, 1997), as the specimens from which ΔSCCs are estimated, can be 
                                                
6 A brief introduction to mixed-effects models is given in section 6 on page 78. 
7 GUI: Graphical User Interface 
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interpreted easily and adequately if starting point and peak of secretory activity is known 
(e.g., sampling is done prior to stress, and 30-40 minutes after stress onset, Dickerson & 
Kemeny, 2004). On the downside, ΔSCCs rely on discrete points in time (i.e., any 
informative change of in-between and outside of bounds of specimen sampling is 
disregarded), which can be problematic, given that dynamic feed-forward and feedback- 
regulation of HPA activity can cause the rise and peaking of SCC to differ between 
individuals. This problem could be partially circumvented by sampling of more than two 
specimens, but this also results in interpretational problems, as the number of possible 
ΔSCCs increases in a quadratic fashion the more specimens are sampled. 
Continuous-time modeling of ΔSCC can provide a solution to these problems, although no 
mechanistic and physiological knowledge about HPA functioning is used. A key aspect of 
the continuous-time modeling of HPA activity rests on the idea that any ΔSCC(ti) within a 
certain fixed time window (Δt = ti – ti-1) also contains information about ΔSCC within any 
other Δt. By standardization of ΔSCC(ti) to length of its corresponding time window Δti 
(Voelkle et al., 2012), a difference quotient ΔSCCi / Δt can be obtained that denotes any 
change of salivary cortisol within one unit of its time scale. This quotient can be 
interpreted similarly to the regression parameter aa of formula I (see page 19). 
Furthermore, proceeding from Bollen and Curran (2004), any ΔSCCi can be modeled by 
essentially the same autoregression that can be used to predict SCC(ti) by SCC(ti-1) [or its 
rearranged form SCC(ti – Δt)]. Integration of both trains of thought results in the 
difference equation given in formula IV, where A is a matrix containing all autogression 
parameters relating the difference quotient ΔSCCi / Δt to any sampling point: 
(IV) !"##(!!)!" = 𝐴 ∗ 𝑆𝐶𝐶(𝑡! − 𝛥𝑡)	  
In the case that Δt converges towards zero, the autoregression matrix A will define the 
slope of SCC at any point in time, and thus become a matrix containing the local drift 
parameters of SCCs. This is formalized by the deterministic differential equation given in 
formula V. Solving formula V yields formula VI (see Appendix A in Voelkle et al., 2012) 
where t0 represents the beginning of the time series (i.e., the initial sampling point). 
(V) !"##(!)!" = 𝐴 ∗ 𝑆𝐶𝐶(𝑡)	  
(VI) 𝑆𝐶𝐶 𝑡 = 𝑆𝐶𝐶 𝑡! ∗ 𝑒!∗(!!!!)	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Implementation of such a model and its extension by Wiener processes (which would in 
the present case assume that randomly occurring SCC deflections from the trajectory 
projected by formula VI persisted throughout the time series) or relating it to concurrently 
assessed psychological constructs, has been extensively elaborated by (Voelkle et al., 
2012) and shall therefore not be discussed any further. 
Although the presented model may render useful to describe the change of SCCs across 
time, it fails to provide an explicit measure of HPA activity due to lack of the 
incorporation of knowledge that may cause change of SCCs. As has been mentioned 
above, the adequate formalization of such mechanisms relies on substantive theory. 
For the modeling of endocrine time-series in particular, the pharmacokinetic compartment 
theory might serve as a reasonable starting point. This theory has originally been 
developed for the analysis of substance absorption, distribution, metabolism and excretion 
within and between different physiological compartments (Bonate, 2011). Each of such 
compartments (e.g., the gastrointestinal tract and the blood) contains a specific amount of 
the investigated substance at each point in time, which is determined by the exchange of 
substance between those compartments (being indicated by various kinetic parameters ki). 
Proceeding from this reasoning, one can directly specify differential equations for each 
compartment that can be integrated into a single physiologically plausible modeling 
system: If we assume, for instance, that a certain amount of substance within the 
gastrointestinal tract (C1: compartment 1) entered the blood (C2: compartment 2) uni-
directionally, we would specify two differential equations VII and VIII; with Ci(t) 
representing the substance concentration at any time in the respective compartment i, ka 
representing the substance’s transfer rate from C1 into C2, and kel representing the 
substance’s clearance rate from C2. 
(VII) !!!(!)!" = −𝑘! ∗ 𝐶!(𝑡)	  
(VIII) !!!(!)!" = 𝑘! ∗ 𝐶!(𝑡)− 𝑘!" ∗ 𝐶!(𝑡)	  
Notably, specimen sampling from C1 is optional, as ka and C1(t) can be estimated as well 
from C2 specimens being sampled across time. Using Laplace transforms (Mayersohn & 
Gibaldi, 1970), both differential equations can be solved and integrated to formula IX. 
Similar to the solution of differential equation V, the equation IX relies on information 
about the initial state of the system. This is indicated by C1(t0); the need to estimate an 
initially available concentration of target substance in C1.  
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(IX) 𝐶! 𝑡 = !!(!!)∗!!!!!!!" ∗ 𝑒!!!"∗! − 𝑒!!!∗! 	  
Adopting the compartment model outlined above for SCCs analysis by assuming that C2 
corresponded to the salivary compartment, from which unbound cortisol was measured 
[i.e., SCC(t) = C2(t)], C1 could be regarded as a latent compartment containing the fraction 
of unbound cortisol to be synthesized per ACTH pulse (before the HPA feedback loop 
inhibits any further CRH and ACTH release). However, its implementation is (yet) 
implausible, because SCC(t0) would contain no cortisol at all. Such an assumption is 
inconsistent with the empirically observable patterns of pulsatile HPA activity (e.g.,  
Brown et al., 2001) that causes cortisol to deviate substantially from zero at any point in 
time. Within a conventional panel design comprising saliva sampling in temporal 
proximity to a single HPA pulse (utilizing HPA stimulation by standardized laboratory 
protocols), we could by contrast use a generalization of formula IX (Gabrielsson & 
Weiner, 2007) for estimating C2(t) after n similar, previous cortisol pulses, that is, SCC(t) 
is assumed to converge towards some minimal SCC(t0) given a fixed phase τ (that defines 
the elapsed time period before C1(t0) is reinstated). The corresponding equation is 
provided in formula X. 
(X)  𝐶! 𝑡 =   𝑆𝐶𝐶(𝑡) = !!(!!)∗!!!!!!!" ∗ !!!!!∗!!"∗!!!!!!!"∗! 𝑒!!!"∗! − !!!!!∗!!∗!!!!!!!∗! 𝑒!!!∗! 	  
As n increases towards infinity and given the substance has been completely transferred to 
C2 as t approaches the phase duration τ, the minimal SCC(t0) can be calculated by formula 
XI, with t0 denoting a point in time that is found between the baseline8 sample and the first 
observable rise of SCCs. 
(XI)  𝑆𝐶𝐶 𝑡! = !!(!!)∗!!!!!!!" ∗ !!!!"∗!!!!!!!"∗! 	  
In order to illustrate an exemplary SCC trajectory in conventional panel design assessing 
acute HPA activity, the model given in formula X was fitted to SCC data reported from a 
TSST-G study (Dawans et al., 2011) using Bayesian inference via Markov-chain Monte-
carlo sampling9 (Jackman, 2009). Figure 4 depicts the TSST-G data and the predicted 
                                                
8 Although the term baseline might imply presence of some resting state, which is clearly not the case for 
any dynamic endocrine system, it will henceforth be used to refer to the initial sample of cortisol time-
series. 
9 The pharmacokinetic model reported in formula X was fitted to the data utilizing JAGS 3.3.0 (Plummer, 
2012) and R 2.15.1 (R Core Team, 2012) statistical software. All priors were chosen to be uninformative. 
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SCC trajectory. As can be seen, the predicted and empirically reported mean SCCs 
correspond quite well. The advantages of the proposed model are evident: If we 
conceptualized HPA activity as resulting from a convolution of HPA reactivity and HPA 
recovery (Johnson & Veldhuis, 1995; Linden et al., 1997), the model parameters of major 
interest certainly are the relative amount of secreted cortisol C1(t0) = 26.06 nmol/L, as well 
as the rate of cortisol secretion ka = 0.083, and the rate of cortisol elimination ke = 0.026 
(interestingly corresponding to a half-life of 27 min), respectively. 
 
Figure 4. Mean salivary cortisol concentrations (SCCs) being obtained from a TSST-G study (Dawans 
et al., 2011) and the corresponding trajectory of SCCs as predicted by a Bayesian continuous-time 
modeling approach. The dotted line denotes the minimal steady-state SCC(t0) (i.e., the level that needs 
to be reached before cortisol is secreted again). The dashed line shows the same SCC trajectory, in 
case no cortisol was secreted in response to the TSST-G. 
However, one could also estimate the overall extent of HPA activity by calculating the 
amount of salivary cortisol that is additionally available as compared to a scenario, where 
                                                                                                                                             
Parameter distributions were obtained from two Markov chains comprising 100,000 iterations, each 
(after a burn-in period of 5,000 iterations), which were thinned in intervals of 10 iterations. The Gelman-
Rubin diagnostic (Gelman & Rubin, 1992) indicated convergence of both chains. Trace plots, density 
plots, and the syntax are provided in the appendix A1. 
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HPA stimulation was unsuccessful (see dashed line in Figure 4). Such a measure can be 
quantified as the difference between the area under the SCC curve given a pulse was 
present (within the time period from t0 = 0 to phase duration τ) and area under the SCC 
curve given no pulse was present (i.e, the time period from t0 = τ to twice the phase 
duration 2τ): 
𝐴𝑈𝐶!"" = 𝐶!(𝑡!) ∗ 𝑘!𝑘! − 𝑘!"∗ 1− 𝑒!!∗!!"∗!1− 𝑒!!!"∗! 𝑒!!!"∗! − 1− 𝑒!!∗!!∗!1− 𝑒!!!∗! 𝑒!!!∗!!! 𝑑𝑡− 1− 𝑒!!∗!!"∗!1− 𝑒!!!"∗! 𝑒!!!"∗! − 1− 𝑒!!∗!!∗!1− 𝑒!!!∗! 𝑒!!!∗!!!! 𝑑𝑡  
Conditional on the validity of the proposed model for mapping SCC kinetics, one could 
use this area under the SCC curve (AUCSCC) to actually quantify cortisol exposure due to 
HPA activity. In contrast to the ΔSCC operationalization of HPA activity (being 
introduced at the beginning of this section), which crucially depends on the time 
specimens are sampled, the AUC is more easily interpretable and represents a more 
holistic operationalization of individual HPA activity. Due to the complexity of its 
calculation, however, other AUC variants have been proposed (e.g., AUCi and AUCg 
being calculated from trapezoidal SCC decomposition; Fekedulegn et al., 2007; Pruessner, 
Kirschbaum, Meinlschmid, & Hellhammer, 2003), which are based on linear interpolation 
between all discrete points in time. Consequently, these variants are no real, but rather 
discrete-time indicators of HPA activity, as the sampling time of specimens is crucial to 
recover the data generating mechanism. Nonetheless, they can be regarded as data-driven 
approximations to the information being provided by continuous-time AUCs (given a 
sufficient number of available specimens), at the expense of their unrealistic theoretical 
assumptions. However, their utility with regard to HPA activity has been supported by 
(Fekedulegn et al., 2007), who showed that a combination of AUCi and AUCg may serve 
well to account for the major fraction of SCC time-series variance. 
3.3.2 Discrete-time modeling 
As a more convenient alternative to the technically difficult, time-consuming continuous-
time modeling, most researchers in the field of psychoneuroendocrinology rely on 
discrete-time GLM techniques to investigate HPA activity across time (see section 3.3.3). 
  26 Induction and quantification of HPA activity 
This is commonly done by reliance on dummy coding of each sampling point in order to 
specify ANOVAs, by which SCC differences at each point in time are related to some 
SCC reference manifestation. Other discrete-time approaches being particular prominent 
with analyses of time series in general, involve the estimation of autoregressions between 
discrete sampling points (see Bollen & Curran, 2004). As such analytical strategies are 
conceptually similar to the analysis of multiple change scores of SCC (ΔSCCs), which has 
been introduced in the former section, all of the corresponding advantages and 
disadvantages apply to discrete-time modeling as well: They provide a way for a data-
driven operationalization of HPA activity and do not rely on mechanistic assumptions 
about HPA activity, but come also along with interpretational problems resulting from the 
calculation of multiple effect parameters. 
If one is willing to accept these conceptual issues for the benefit of the easy 
implementation of discrete-time models, the only remaining considerations concern 
auxiliary statistical hypotheses that need to be valid in order to drawn unbiased 
conclusions about the parameters being estimated (see section 3.3). With regard to the 
analysis of SCCs, discrete- and continuous-time models share the assumptions about the 
distributional shape and the homoscedasticity of residuals, but the major difference 
between both relates to their covariance structure. For “toolbox” repeated-measures 
ANOVAs, the covariance structure between all sampling points is supposed to satisfy 
compound-symmetry (or sphericity), that is, residuals of all sampling points are supposed 
to be uncorrelated after controlling for individual variation within SCC reference variable 
(which is commonly the baseline sample prior to HPA stimulation). This assumption will 
be appropriate, if only two specimens are sampled per participant. If, however, more than 
two specimens were obtained, compound symmetry would be unrealistic. Sakia (1992) 
reported four options to deal with such situations: 
(1) Ignore the violation of assumptions, and proceed as if they were satisfied. 
(2) Model the assumptions appropriately. 
(3) Make the model satisfy the assumptions. 
(4) Use a distribution-free, non-parametric procedure. 
Acknowledging the need for convenient, but powerful and justifiable statistical 
procedures, the present thesis is predominantly concerned with the options (2) and (3). 
While latter has been the most popular option for a long time (and shall be addressed in 
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chapter 5), option (2) can nowadays also be easily implemented. This is achieved by the 
use of generic tools for moment structure analysis (e.g., Mplus [Muthén & Muthén, 2010], 
OpenMx [Boker et al., 2011], or Lavaan [Rosseel, 2012]) and the possibility to specify 
complex moment structures by reliance on path notation for discrete-time modeling, 
which is introduced in chapter 6. Furthermore, this path notation can serve as a convenient 
means to incorporate and test complex hypotheses about HPA activity. 
3.3.3 Brief literature review: HPA activity from 2010 to 2012 
3.3.3.1 Search strategy and study selection 
In order to examine the current and past use to statistical techniques for quantifying HPA 
activity, all issues of Psychoneuroendocrinology from January 2010 to December 2012 
were screened for published original articles investigating cortisol as a biomarker for acute 
HPA responses. Specifically, a search for relevant literature was performed on 
sciencedirect database by the 4th of February 2013, to identify all original articles 
containing the keywords TSST and cortisol. Furthermore, 8 articles, which have been 
published online in 2012 but not been printed yet, were also included in the analyses. This 
procedure resulted in a set of 68 candidate studies, of which 11 studies were discarded due 
to assessment of circadian HPA activity (i.e., single pulses had not been investigated) or 
pharmacological challenges that were repeated with short time lags (i.e., multiple 
overlapping pulses have been investigated). 
3.3.3.2 Results and discussion 
52 studies used psychosocial stressors to induce HPA axis activity, of which two studies 
also investigated the cortisol awakening response (CAR), and pharmacologically induced 
HPA activity by CRH administration, respectively. Four other studies only examined the 
CAR. One study solely examined CRH-induced HPA activity. 
With 94.7%, the majority of studies (N = 54) investigated time-dependent change of HPA 
activity by discrete-time modeling based on the GLM. Remarkably, approximately 56.1% 
of all studies did not (exclusively) rely on model-based operationalization of HPA activity, 
but used discrete-time summary measures (i.e., trapezoidal AUCs or change from baseline 
to peak cortisol concentrations) for quantification of HPA activity across time. The 
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relative frequency of these proxies for HPA activity quantification is visualized in Figure 
5. Only three studies performed continuous-time modeling, of which two studies utilized 
mixed-effect polynomial regression (Brown, Weinstein, & Creswell, 2012; Dienes, Hazel, 
& Hammen, 2012). The third study fitted a nonlinear mixed-effects model from which 
continuous-time AUCs (and various other parameters) were estimated (Stroud, 
Papandonatos, Williamson, & Dahl, 2011). 
 
Figure 5. Relative frequency of studies being published in Psychoneuroendocrinology that used 
discrete-time area-under-the-curve (AUC) and/or baseline-to-peak increase (BPi) measures to 
quantify HPA activity. 
The main result of this brief review, that is, discrete time modeling is more popular than 
sophisticated continuous-time modeling, was quite unsurprising due to the relative inertia 
of scientific domains to adopt unfamiliar methodology. It is nonetheless astonishing, that 
many stress researchers tend to supplement their analysis with measures of HPA activity, 
which have originally been developed for continuous-time models. One might 
hypothesize, that the multidisciplinarity of stress research may be the driving force behind 
this finding: Such multidisciplinarity is likely to be reflected in journals’ peer-review 
systems and thus forces researchers to broaden their method portfolio. The popularity of 
the trapezoidal AUC-calculation in particular, may have been moderated by Pruessner and 
colleagues' (2003) influential article (857 citations), which highlights the need for readily 
adaptable solutions to the quantification issues with HPA activity, that stress researchers 
are regularly confronted with.   
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4. The pitfalls of SCC measurement 
4.1 Overview 
As has been previously mentioned in chapter 3, statistical analyses of SCCs, which are 
based on the general linear model, rely on several auxiliary hypotheses (particularly 
presence of homoscedasticity and normal distribution of model residuals), that need to be 
fulfilled in order to drawn unbiased conclusions on the parameters being investigated. 
However, upon utilization of the most popular biochemical tools to determine SCCs, that 
is, conventional immunoassays, these auxiliary hypotheses most likely need to be 
discarded. Such measurement-related issues shall be discussed in the present chapter that 
is mostly based on a technical report of (Miller et al., 2013). 
First, the assumption of homoscedaticity is likely to be violated due to the immunoassays’ 
measurement models, which are used to infer on cortisol concentrations within saliva 
specimens. These models are commonly based on four-parameter logistic functions that 
relate the measured signal (e.g. the luminescence) to a certain concentration on a log scale. 
Such a measurement model is exemplarily depicted in Figure 6, and highlights the 
emergence of heteroscestasticity that occurs upon the prediction of naturally scaled 
cortisol concentrations from such a measurement signal: Even if the measurement model 
was correct, any signal x that scattered randomly around its mean would alter the 
distribution of its corresponding cortisol concentration SCC(x) on it natural scale. This 
distribution can be ascribed by the respective power law, implying that any signal 
fluctuation at a lower signal level Δx2 (as compared to a higher signal level Δx1) will 
eventually result in an exponentially larger SCC variance at higher concentration levels. 
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Figure 6. Exemplary illustration of a four-parameter logistic reference curve for a chemiluminescence 
immunoassay. The curve serves to relate some measured signal (on the y-axis) to its corresponding 
log-scaled cortisol concentrations. On its natural scale, cortisol concentrations become exponentially 
larger as the measures signal linearly decreases.  
Second, and regardless of the actual distribution of SCCs (which shall be discussed in 
chapter 5), immunoassay results are subject to interference of matrix components. With 
SCCs, the major source of such interference is presumably its main metabolite, cortisone, 
which has different kinetic properties (i.e., a prolonged half-life; see Perogamvros et al., 
2011), and competes with cortisol for available IA antibodies. Accordingly, measured 
SCC distributions will be altered depending on the specimens’ temporal proximity to the 
preceding secretory pulse of the HPA axis. 
Both issues shall be investigated in section 4.2 by performance comparisons of different, 
commercially available SCC immunoassays to liquid chromatography coupled with 
tandem mass spectrometry, which is due to its extremely high specificity (i.e., virtually no 
cross-reactivity with saliva matrix components) considered as “gold standard” for SCC 
determination (Perogamvros et al., 2012). Finally, section 4.3 includes a simulation study, 
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which illustrates the impact of matrix interference and growing measurement error on 
empirically derived SCC distributions. 
4.2 SCCs as measured by immunoassays and tandem mass spectrometry 
4.2.1 Introduction 
Due to its non-invasiveness, precision, and cost efficiency the measurement of steroid 
levels from saliva has become a valuable tool in psychoneuroendocrinological research 
over the past two decades. While other steroid hormones are also measured with 
increasing frequency, cortisol still represents the prime hormone assessed in saliva 
samples collected in basic stress research, epidemiological, as well as clinical studies 
(Kirschbaum & Hellhammer, 1989; 2007). 
The vast majority of salivary cortisol determinations are performed using immunoassays 
(IA). These IAs rely on chemical binding of analytes to antibodies, which show varying 
specificity for molecules to be detected and quantified.  Although these antibodies are 
specifically raised to bind analytes selectively, structurally related substances in the same 
specimen compete with the analyte for available binding sites. For the determination of 
salivary cortisol, a major source of such interference is cortisone, which is abundant in 
saliva due to cortisol oxidation via 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) 
in the parotid glands (Smith et al., 1996). Cortisone cross-reactivity is especially 
important, considering that its concentration amounts to, due to its prolonged half-life, on 
average 280% as compared to cortisol (Perogamvros et al., 2011), implying that its impact 
is supposed to be more pronounced with increasing temporal distance from the preceding 
secretory cortisol burst. This would eventually result in rising cortisone-to-cortisol ratios, 
with decaying cortisol concentrations. 
Additionally, antibody design varies across different IAs, resulting in differential analyte 
and matrix affinity (cf. Davies, 2005). Thus, measuring identical samples with different 
IAs can result in absolute analyte concentrations that differ by a factor of three or more 
between separate IAs (Kirschbaum & Hellhammer, 1989; Raff, Homar, & Burns, 2002). 
The same seems to apply to blood plasma specimen (Cohen, Ward, Prins, Jones, & 
Venkatesh, 2006; Roberts & Roberts, 2004). Furthermore it has been demonstrated, that 
most IAs’ results overestimate absolute cortisol levels in saliva when compared with data 
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obtained by mass spectrometry as reference method (Jönsson, Malmberg, Amilon, Garde, 
& Ørbæk, 2003). Although absolute steroid levels may not be of prime importance for 
most studies conducted for research purposes only, it would be advantageous if salivary 
cortisol levels could be compared with each other across different studies, and assay 
technologies. 
Based on this, the present report serves two main purposes. First, we aim to evaluate 
salivary cortisol results obtained by IAs most frequently used in 
psychoneuroendocrinological research for the last four years, and compare them to results 
obtained with liquid chromatography tandem mass spectrometry (LC-MS/MS). Our 
second aim is to investigate the influence of cortisone cross-reactivity on salivary cortisol 
as determined by the respective IAs. Apart from these major points, we further intend to 
provide preliminary conversion guidelines, which shall enable the comparison of salivary 
cortisol data from different studies, but should be utilized with caution considering that IA 
manufacturers occasionally change IA antibodies and/or other components across time. 
Nonetheless, they may render helpful to, for example, perform meta-analyses of raw mean 
differences (cf. Bond, Wiitala, & Richard, 2003) or interpret absolute cortisol values. The 
latter is particularly important within the clinical practice, as transgression of threshold 
criteria for steroid levels has been frequently employed as an indicator for adrenocortical 
functioning (e.g., Trilck, Flitsch, Lüdecke, Jung, & Petersenn, 2005). 
4.2.2 Methods 
4.2.2.1 Sample 
195 saliva specimen, which had been obtained using Salivettes® (Sarstedt, Nümbrecht, 
Germany; see Gröschl, Köhler, Topf, Rupprecht, & Rauh, 2008), were randomly drawn 
from a larger pool of saliva samples. The pool comprised specimen being mostly collected 
from healthy (i.e. free of glucocorticoid or other medication) subjects during psychosocial 
stress studies. A minority of specimen from pharmacological challenge studies was 
selected in order to cover cortisol levels in the upper measurement range. Therefore 
absolute cortisol levels were expected to comprise circadian and ultradian variability 
within the natural, non-pathological cortisol spectrum, as well as to a smaller extent 
pharmacologically altered levels. 
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4.2.2.2 Preanalytical precautions 
Specimen were aliquoted and stored at -20°C for up to six months before they were sent to 
reference laboratories in Erlangen and Trier (Germany). Although salivary cortisol 
remains stable for at least four days at room temperature (Gröschl et al., 2008), aliquot 
shipment was conducted in cooled boxes to prevent cortisol degradation. Repeated 
thawing and freezing of specimen and storage at -20°C for up to 12 months is reported to 
have no sustainable effect on salivary cortisol concentrations (Garde & Hansen, 2005). 
4.2.2.3 Biochemical analyses by IAs 
Upon arrival at the respective destination, aliquots were analyzed with either four 
commercial IAs (IBL, DRG, Salimetrics, and DSL; see Table 2), or with one in-house 
method (DELFIA; Dressendörfer, Kirschbaum, Rohde, Stahl, & Strasburger, 1992). An 
insufficient amount of saliva in one aliquot for the DELFIA assay resulted in failure to 
determine cortisol and thus one missing data point. All IAs comply with the European 
directive on in-vitro diagnostic medical devices, and were conducted according to the 
specifications and protocols provided by the manufacturers, or as described in detail 
elsewhere (Dressendörfer et al., 1992). Lower quantification limits were below 0.5 nmol/L 
for all IAs. Cross-reactivity with cortisone and other substances varied substantially across 
IAs, and has been altered during the last for years due to antibody changes (see Table 2). 
4.2.2.4 Biochemical analyses by LC-MS/MS 
Salivary cortisol was also determined by LC-MS/MS, which exhibits better specificity, 
and thus served as reference for the IAs. Sample preparation, apparatus and system 
parameters were essentially identical as reported in Rauh et al. (2006). For analysis, an 
online extraction method with a column-switching technique, combined with analytical 
LC-MS/MS and APCI was used. Temperature of the APCI source was set to 500°C. 
Analyses of specimen were performed in a multiple-reaction monitoring (MRM) mode 
with a dwell time of 150 ms. Transitions for quantification (and qualification) were 
adjusted with respect to the analyte (cortisol) and internal standards (cortisol 
D4[9,11,12,12-D4]): m/z 363·2/121·2 (363·2/309·4) cortisol and m/z 367·3/121·2 cortisol 
D4. The collision energy (quantifier/qualifier) used was 35/25 eV for cortisol.	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Linearity of the assay was evaluated across a concentration range of 0.14 – 690 nmol/L 
yielding a correlation of r > .99. The lower quantification limit was 0.55 nmol/L, whereas 
the lower detection limit was 0.08 nmol/L being derived at a signal-to-noise ratio of 3. 
Intra- and inter-assay coefficients of variation ranged from 5.0% – 1.9 %, and 7.7% - 3.8% 
respectively. In order to check for interference, two MRMs were conducted for each of 
two steroids; cortisone and aldosterone. The intensity ratio of the quantifier and qualifier 
MRM was required to be ±30% of the standard ratio. No interference was observed. 
4.2.2.5 Statistical analyses 
All statistical analyses were performed using Mplus (Muthén & Muthén, 2010) and the 
mice-package (van Buuren & Groothuis-Oudshoorn, 2011) with R 2.15.0 statistical 
software (R Core Team, 2012). Assuming that data was missing completely at random, we 
performed multiple imputations (n = 5) by chained equations prior to data analysis. In 
order to obtain initial information on the relation between salivary cortisol as determined 
by LC/MS-MS and the five IAs, we applied a nonparametric regression procedure: Curve 
fitting on scatterplots via locally weighted polynomial regression for each comparison (of 
LC/MS-MS reference with the respective IA values), using tri-cubic kernel functions for 
weighting (loess; Cleveland & Devlin, 1988) in cortisol data point fractions of 66.7% 
centered around the point of interest, indicated nonlinear model components. 
However, conventional regression approaches assume that only criterion, but no predictor 
variables comprise measurement errors. This issue of particular importance for the 
purpose of the present report, as the predictor variable we used (i.e., the LC-MS/MS 
results) also exhibits intra-assay variation. Thus, measurement models were constructed to 
validate the loess models and estimate latent true cortisol concentrations from LC/MS-MS 
and IA data using structural equation modelling. Parameters were obtained by maximum 
likelihood estimation. Due to severe deviation from multivariate normality (Finney & 
DiStefano, 2006), chi-square fit statistics were rescaled according to Satorra and Bentler 
(2001). Obtained p-values were cross-validated using Bollen-Stine bootstrapping (Bollen 
& Stine, 1992). Furthermore a selection of fit indices (Hu & Bentler, 1998) was utilised to 
judge the quality of model fit. 
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Table 2. Characteristics of the immunoassays (IAs) distributed by the respective manufacturer in 
2008 and 2012. 
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Note. Distribution of the DSL kit has meanwhile been ceased after acquisition of Diagnostic 
System Laboratories by Beckman Coulter. Another available high sensitivity DRG kit features a 
higher cross-reactivity with cortisone (6.9%). CLIA = chemiluminescence IA, EIA = enzyme IA, 
17α-OHP = 17α-hydroxyprogresterone, DEX = dexamethasone, NA = not available/not 
determined by manufacturer. 
 
  36 The pitfalls of SCC measurement 
The reference model A comprised a freely estimated one-factor-solution (a canonical 
variate incorporating the variance shared by all assays), which is similar to linear 
measurement error models (also known as orthogonal, total least squares, or Deming 
regression; see Davies, 2005) but does not require any constraints on residual assay 
variances. Due to a substantial amount of residual covariance between the IAs, which was 
presumably due to the common nonlinearity, that we observed with some of the initial 
assay comparisons, another model B was fitted to the data, extending model A by a 
second, orthogonal factor. Factor loadings for this factor were freely estimated and 
correlated with IA-specific cortisone cross-reactivity (see results section). Proceeding 
from model B, we estimated cortisol factor scores, which were assumed to be free of 
measurement error. 
Due to the intent to also provide parametric conversion functions, salivary cortisol as 
determined by the IAs was finally regressed on cortisol factor scores by both 
nonparametric loess (Cleveland & Devlin, 1988) and weighted least squares (WLS) 
polynomial regression models. Model intercepts were fixed to zero. Case weights were 
implemented as inverse of the local error variance, which was estimated by applying 
smoothing splines10 to the loess models’ log-squared residuals (Wasserman, 2006). 
Smoothing parameters were fixed to λ = 0.1. Subsequently, the resulting fitted values 
were exponentiated and interpolated with cubic splines. Heteroscedasticity of models’ 
residuals was assessed according to Breusch and Pagan (1979). 
In order to check for nonlinearity of the parametric IA mappings, we applied a stepwise 
forward predictor inclusion algorithm comparing models’ Bayesian Information Criteria 
(BIC; Schwarz, 1978) to account for the trade-off between prediction accuracy and 
parameter parsimony. Significance of the association between nonlinearity and IA-specific 
cortisone cross-reactivity was evaluated by permutation tests. 
                                                
10 The smoothing approach we chose minimizes the area under the squared second derivate of the target 
functions, implying utilization of cubic piecewise polynomials (splines). 
  37 The pitfalls of SCC measurement 
4.2.3 Results 
4.2.3.1 General results 
Descriptive statistics for salivary cortisol as determined by all IAs and LC-MS/MS, and 
correlations between these assays are reported in Table 3. Salivary cortisol is strongly 
skewed and exhibits low data density in the upper measurement range. As Loess requires 
densely sampled data points in order to produce reliable local estimates, prediction will 
eventually become increasingly inaccurate with rising cortisol concentrations (see Table 
5). Furthermore estimation of the error variance functions, which are used for parametric 
WLS modeling, suggests an exponential increase of variance with increasing salivary 
cortisol level. This leads to increasing inaccuracy of parametric models and indication of 
heteroscedasticity in Breusch-Pagan tests. 
Table 3. Descriptive statistics and correlation matrices for salivary cortisol as determined by IBL, 
DRG, Salimetrics, DSL, DELFIA, and LC-MS/MS. Pearson product-moment correlations (r) are 
reported below the main diagonals of the correlations matrices. Spearman rank correlations (ρ) are 
reported above the main diagonals. 
 LC-MS/MS Immunoassays 
 IBL DRG Salimetrics DSL DELFIA 
Moments       
  Mean 13.44 23.46 22.86 17.12 48.13 15.97 
  SD 20.65 23.38 24.24 22.82 44.48 20.12 
  Skewness 2.87 1.76 2.43 3.06 1.94 2.47 
  Kurtosis 12.92 6.57 10.30 14.77 8.33 9.80 
Percentiles       
  Minimum 0.01 0.35 0.91 0.51 0.16 0.12 
  1st quartile 1.64 6.43 8.13 4.14 14.58 3.38 
  Median 5.37 15.17 14.44 9.28 37.64 8.91 
  3rd quartile 15.65 33.83 28.53 19.38 63.79 19.14 
  Maximum 140.04 132.74 158.43 166.07 284.30 118.32 
Correlations       
  LC-MS/MS  .96 .93 .96 .92 .96 
  IBL .93  .91 .96 .96 .99 
  DRG .93 .95  .91 .86 .90 
  Salimetrics .95 .89 .87  .93 .96 
  DSL .90 .96 .92 .85  .96 
  DELFIA .97 .94 .91 .92 .91  
Note. All values refer to salivary cortisol scaled in nmol/L.  
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As a consequence, we decided to restrict the reported results to salivary cortisol 
distributions that were truncated at the 95th LC-MS/MS percentile. Within our sample, this 
applied to all values larger than 60 nmol/L. As indicated by initial data inspection, there 
were nonlinear mappings of LC-MS/MS reference cortisol on salivary cortisol as 
determined by the five IAs. The extent of this observed nonlinearity seems to reflect IA-
specific cortisone cross-reactivity. 
4.2.3.2 Measurement models 
The established reference measurement model A, which assumes the existence of only one 
latent salivary cortisol factor across all assays, yielded a poor overall model fit [χ2(14) = 
41.32, p < .001; Comparative Fit Index (CFI) = .85; Bayesian Information Criterion (BIC) 
= 8877.03; Root Mean Square Error of Approximation (RMSEA) = .10; Standardized 
Root-Mean-square Residual (SRMR) = .11] due to a substantial covariance between the 
assays’ residuals. Assuming that a certain fraction of this covariance resulted from 
nonlinearity, which was shared only by the IAs, we compared measurement model A with 
the extended measurement model B comprising a second, freely estimated orthogonal 
factor. Fitting model B to the data resulted in a good agreement between model-implied 
and actual covariance [χ2(8) = 10.18, p = .25; CFI = .99; BIC = 8526.15; RMSEA = .04; 
SRMR = .03] and predicted the data significantly better than model A [χ2(6) = 27.69, p < 
.001] even if parameter parsimony was taken into account. Statistical power of this 
comparison (MacCallum, Browne, & Cai, 2006) was sufficiently large [1−β = .98]. 
Loadings of the “nonlinearity” factor, and cortisone cross-reactivity as reported by the 
respective IA manufacturer correlated significantly [r = .99, p < .01]. Measurement model 
B is presented in Figure 7. Finally we estimated salivary cortisol factor scores from model 
B, which were supposed to reflect salivary cortisol concentrations without bias due to 
measurement error and cortisone cross-reactivity. 
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Figure 7. Path diagram of measurement model B showing unstandardized factor loadings. Rectangles 
represent the manifest variables (i.e., LC-MS/MS and the immunoassays IBL, DRG, DSL, Salimetrics, 
and DELFIA). Ellipses represent the latent factors (i.e., Salivary Cortisol, and Nonlinearity). 
Incorporation of systematic covariance due to IA-specific nonlinearity accounts significantly better for 
the data than the nested one factor measurement model A [χ2(6) = 27.69, p < .001]. Loadings of the 
Nonlinearity factor correlate significantly with cortisone cross-reactivity of the respective IA [r = .99, 
p < .01]. For reasons of clarity, residual variances (εn) and mean structure are not shown in the figure. 
4.2.3.3 Regression models 
Fitting and comparing parametric regression models supports the assumption of nonlinear 
“true” salivary cortisol mappings, which are due to cortisone cross-reactivity, on salivary 
cortisol as determined by the IAs. Scatterplots including regression lines of loess and 
parametric models are depicted in Figure 8. All polynomial models fit the data 
significantly (ps < .001) better than their linear counterparts. Even upon penalizing model 
complexity via BIC, polynomial regressions are to be preferred (see Table 4). The 
incremental prediction value of the nonlinear models, as indicated by likelihood ratios, 
correlates significantly with cortisone cross-reactivity of the respective assay [ρ = .89, p < 
.05]. 
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Prediction of linear and polynomial models becomes increasingly inaccurate with rising 
cortisol concentrations (see Figure 8). With regard to linearity the DELFIA IA works best, 
followed by the Salimetrics. IBL, DRG and DSL IAs exhibit a more pronounced 
nonlinearity towards low salivary cortisol concentrations. Prediction accuracy of salivary 
cortisol factor scores is by far worst for DSL (see Table 4). Concerning the fitted 
polynomial models, the likelihood of the predicted IA salivary cortisol values given the 
actual data is again largest for the DELFIA IA. IBL and DSL models benefit most from 
the inclusion of nonlinear components, although the latter still remains the most 
inaccurate. Unexpectedly the Salimetrics model benefits from the inclusion of nonlinear 
components to an extent comparable to that of the DRG IA, which cannot be just due to 
cortisone cross-reactivity. However this might also be a statistical artefact as the IA 
release we utilized only yields valid results for cortisol concentrations up to 50 nmol/L11. 
In order to provide researchers with the opportunity to compare salivary cortisol as 
measured by the different IAs, Table 5 lists estimated salivary cortisol factor scores, 
corresponding percentiles, predicted assay values, and 95% confidence bands. As the 
opportunity to convert cortisol factors scores into cortisol as determined by the respective 
IA, but not vice versa, might be of limited use for researchers and clinicians, we 
furthermore created an online conversion tool, which is based on the estimated inverse of 
the provided polynomial regression models (see appendix A2). This tool is supplied at 
http://psylux.psych.tu-dresden.de/i1/biopsych/ac.html. We strongly emphasize that 
utilizing the conversion functions provided with this report to extrapolate beyond the 60 
nmol/L (LC-MS/MS) threshold, or to generalize them to contemporary IA releases may 
not yield valid prediction results. 
                                                
11 The current release of the Salimetrics IA has an extended range up to 3 µg/dL (82.8 nmol/L). 
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Figure 8. Panels show salivary cortisol as determined by IBL, DRG, DSL, Salimetrics, and DELFIA 
immunoassays (IAs) on the y-axis, which are plotted against estimated true salivary cortisol (factor 
scores) on the x-axis. Solid lines represent IA-specific parametric polynomial regression functions, 
dashed lines non-parametric Loess regressions, and dot-dashed lines linear regressions. 
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Table 4. Coefficients and fit statistics of parametric regression models predicting salivary cortisol of 
the respective IA by estimated true cortisol (factor scores). For each IA linear reference and 
polynomial models yielding smallest BIC are contrasted. 
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Table 5. Conversion table for estimating SCCs as determined by the different assays. Values are 
obtained by polynomial regression on cortisol factor scores. 
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4.2.4 Discussion 
The purpose of the present technical report was to compare salivary cortisol levels 
obtained by the most frequently employed immunoassays (IAs) by relating them to 
cortisol levels measured with liquid chromatography coupled with tandem mass 
spectroscopy (LC-MS/MS). In a second step, we aimed to check for the influence of 
cortisone cross-reactivity on the determination of cortisol concentrations. 
In line with findings published over a decade ago (Kirschbaum & Hellhammer, 1989; Raff 
et al., 2002), absolute salivary cortisol values obtained with different commercial or in-
house IAs are still barely comparable. Large absolute differences between individual IAs 
call for greatest caution when interpreting individual and group cortisol data measured 
with different analytical methods. Due to assay-specific measurement error, a direct 
comparison of salivary cortisol between IAs is not feasible and thus can only be conducted 
indirectly via cortisol factor scores, which are obtained from a measurement model. In 
order to allow conversion of salivary cortisol data from one of the most frequently used 
IAs (IBL, DRG, Salimetrics, DSL, and DELFIA) into corresponding salivary cortisol 
factor scores, we provide researchers with a conversion table and an online conversion 
tool, which have been obtained from prediction functions. On utilization of the provided 
functions agreement between different releases of the same IAs (as documented by the 
respective manufacturer) and varying prediction accuracy have to be taken into account. 
Prediction accuracy (i.e., the distance between IA cortisol and “true” cortisol) varies 
across the measurement range depending on the underlying regression model. With 
conventional linear models, lower IA cortisol values are underestimated, whereas higher 
values are overestimated (see Figure 8). This accuracy decrease towards low and high 
values is presumably due to two different causes. 
Accuracy decrease towards lower cortisol values is assumed to reflect the impact of cross-
reactive saliva matrix antigens (mostly cortisone; cf. Smith et al., 1996) that increases with 
decreasing cortisol values. We show that this issue can be successfully addressed by the 
inclusion of nonlinear model components. Nonlinear models predict IA cortisol 
significantly better than their linear counterparts. The extent of this nonlinearity seems to 
depend on IA specificity and cortisone-to-cortisol ratio, which becomes larger with 
decreasing salivary cortisol due to differential kinetic properties of cortisone and cortisol 
(Perogamvros et al., 2011), but might as well be due to further saliva matrix components 
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(e.g., aldosterone, 17α-OHP or synthetic glucocorticoids). This notion is underpinned by 
the finding, that the respective amount of residual (co)variance correlates highly 
significant with assay-specific cortisone cross-reactivity. Furthermore the likelihood ratio 
between linear and nonlinear models covaries with the cortisone cross-reactivity of the 
respective assay. Consistently, a saturation of 11β-HSD2 at high salivary cortisol 
concentrations (cf. Perogamvros et al., 2009) would lead to increasing linearity with 
growing cortisol values, which could be observed with the presented data. 
The decrease in accuracy towards higher cortisol values, however, which occurs with 
linear and nonlinear models, is likely to reflect IA signal properties. It results in an 
exponential error-variance increase and thus heteroscedasticity of models’ residuals with 
rising cortisol values. 
With regard to limited operational ranges, as reported by the IA manufacturers, and low 
predictability of large cortisol values (of the respective IAs), we advise to refrain from 
interpretation of converted salivary cortisol values below 0.5 nmol/L and above 60 nmol/L 
(LC-MS/MS, 95th percentile). Specimen containing larger concentrations are unlikely to 
occur within the non-pathological cortisol spectrum (cf. Veldhuis et al., 1989), given that 
salivary cortisol reflects unbound plasma cortisol (Kirschbaum & Hellhammer, 1989). 
However within-IA-variability across time, which results from occasional changes of 
antibody design or other IA components (e.g. wash buffer or calibrators), may restrict the 
applicability of the provided conversion functions. Despite of manufacturers’ endeavors to 
maintain IA-specific measurement levels, bias due to changes is in fact inevitable12. Thus 
we project to continue with periodical evaluations of the correspondence between popular 
IAs and LC-MS/MS in order to monitor any change that might cause measurement bias 
across time, and enable long-term comparability of cortisol determinations. 
                                                
12 According to internal quality monitoring, IBL International scheduled an antibody change in early 2008 
(y1: RE6201B01), which caused a measurement bias as compared to earlier versions (x: RE6201A03; y1 
= 0.916x - 0.018). Thus, the development of a new antibody was initiated immediately. The revised IA 
(y2: RE6201C01) was launched in early 2009 and maintained since then, exhibiting better agreement of 
analytical results (y2 = 0.987x - 0.010). Salimetrics also reported an antibody change (x: Cat# 1-0102/1-
0112; to y: Cat# 1-3002/1-3012) (y = 0.954x – 0.023) since 2008. The Trier lab (DELFIA) and DRG 
reported no antibody change, but DRG has been distributing two different salivary cortisol ELISAs for 
the last four years. 
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4.3  Biased SCC distributions due to saliva matrix interference 
4.3.1 Introduction 
Although the results reported in the previous section (2.2; Miller et al., 2013) seem to 
qualify mere analyses of saliva specimen for cortisol by means of immunoassays without 
controlling for cross-reactivity and growing measurement error, their relevance for 
discrete-time modeling of HPA activity remains to be illustrated. As GLM modeling 
assumptions mostly relate to data distributions, the mean and variance of the transformed 
(baseline) SCC data reported by Miller & Plessow (2013) was used to define properties of 
a reference distribution of true SCCs13, which was assumed to indicate unconditional HPA 
activity within a corresponding human population (for details, see section 5.3) and 
therefore comparable to a distribution that results from cross-sectional saliva sampling in 
afternoon sessions. Proceeding from this distribution, a simulation study was carried out in 
order to unveil the effect of the nonlinear relation between true and measured SCCs as 
reported by Miller et al. (2013) on data, that would be obtained by the IBL immunoassay.  
4.3.2 Simulation 
R 2.15.1 statistical software (R Core Team, 2012) was used to perform all simulations and 
analyses. Based on the data reported by (Miller & Plessow, 2013), 100,000 random 
samples were drawn from a normal distribution N(2.4, 1.25), which were subsequently 
transformed by X = (0.15*X’ + 1)6.67 to the raw nmol/L scale in order to obtain a 
distribution, that was comparable to a typical sample of SCCs (see Miller & Plessow, 
2013). In accordance to Miller et al. (2013), all data points larger 60 nmol/L were 
dropped. These simulated data was converted via the IBL IA conversion function provided 
by  Miller and colleagues. Both sample distributions were compared by Kolmogorov-
Smirnov tests (KS; Wilcox, 2005). Histogram bin sizes were calculated according to 
(Freedman & Diaconis, 1981). 
                                                
13 The author is fully aware, that the distribution estimated by Miller & Plessow (2013) rests on SCC data, 
which has been obtained by the IBL immunoassay and is therefore already biased. Nonetheless, this 
distribution shall only serve as a basis for subsequent demonstration of such a bias, given the conversion 
functions of Miller et al. (2013) are valid. 
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4.3.3 Results and discussion 
The KS two-sample distribution test of true SCCs versus measured SCC distribution 
yielded a test statistic D = 0.41, which corresponds (given the sample sizes) to p < .001, 
that is, both samples were unlikely to be drawn from the same distribution. Thus, matrix 
interference and growing measurement error as reported in Miller et al. (2013) is most 
likely to substantially alter SCC distributions. Figure 9 depicts the distributions of both 
simulated data, true SCCs and hypothetically measured SCCs. As can be seen measured 
SCCs (median = 19.22, IQR = 19.07) were higher than true SCCs (median = 7.67, IQR = 
9.88). Furthermore, conversion resulted in a reduced distributional skewness to the right 
(true SCCs: 2.64, to measured SCCs: 1.13). Nonetheless, measured SCCs still differed 
significantly from a normality (D = 0.07, p < .001). 
 
Figure 9. Histograms and kernel density estimates of true salivary cortisol concentrations (based on 
data reported by Miller & Plessow, 2013) and measured salivary cortisol concentrations (calculated 
with conversion functions from Miller et al., 2013). 
Although the technical report which informed the present simulation mainly highlighted 
conversion issues that researchers need to take into account with between-study (or at least 
between-laboratory) comparisons of HPA axis parameters, it also pointed towards issues 
regarding the auxiliary statistical hypotheses being associated with analyses of endocrine 
data that is obtained by immunoassays. These auxiliary hypotheses mostly concern the 
distribution of measured SCCs that commonly violates normality. Specifically, the extent 
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of distributional skew being inflicted on SCCs depends on the extent of IA cross-reactivity 
with interfering substances within the saliva matrix, of which cortisone is suggested to 
yield the major contribution.  
The present simulation illustrated, that the true cortisol signal is more prone to substantial 
deviation from normality than measured SCCs. Consequently, even cross-sectional SCC 
data is unlikely to be suited for conventional discrete-time GLM-based modeling. This 
bias issue is additionally aggravated in SCC panel data by the dependence of measurement 
error on the measured level of SCC (see section 4.2). However, the major source of the 
skewness being observable with SCCs may arise from the dynamics of HPA activity, 
which still needs to be clarified. 
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5. Creating normality and homoscedasticity: GLM-based 
analyses 
5.1 Overview 
As outlined in the previous chapter, salivary cortisol is subject to enzymatic conversion by 
11β-HSD2, which causes a measurement bias in the lower range of IA-based SCCs due 
antibody cross-reactivity and different kinetics of cortisol and cortisone in saliva. Such 
signal interferences of saliva matrix components alter the distributional properties of SCCs 
(see chapter 4; Miller et al., 2013), and thus restrict discrete-time modeling based on the 
GLM, as it relies on the validity of several auxiliary statistical hypotheses (see section 
3.3). Additionally, inherent characteristics of biochemical measurement cause the 
measurement error to depend on the magnitude of SCC signals entailing heteroscedasticity 
(Miller et al., 2013), which may also prevent unbiased inference on GLM parameters in 
case the unweighted sum of the model’s squared residuals (OLS) is optimized14.  
Regardless of these measurement-related issues, one may further assume, that the complex 
kinetics of HPA activity in general may also generate SCC distributions, which violate the 
assumptions of normality at any point in time. Such violations would impose additionally 
analytical burden beyond the signal interference due to salivary cortisone and signal error 
in measurement model. Thus, in a first step, a Monte Carlo simulation study is presented, 
which illustrates (based on knowledge about “baseline” HPA activity), why SCC 
distributions are most likely to violate the assumption of normality at any sampling point. 
Furthermore, the present chapter aims to provide solutions to these issues in case one 
intends to rely on discrete-time GLM techniques in order to infer on change of HPA 
activity across time as indicated by SCCs. Apart from relaxing the GLM auxiliary 
statistical hypotheses by moment structure modeling, a quite popular approach is to force 
the input data to satisfy all GLM assumptions, but quite often, both approaches are united. 
The most popular example is the specification of compound symmetrical SCCs (i.e., the 
SCCs’ residuals at all points in time are supposed to be correlated to the same extent) by 
                                                
14 Weighted least squares (WLS) estimation can provide a solution to the presence of heteroscedasticity in 
case the local variance is known. 
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application of mixed-effects (or repeated measures) ANOVAs. Nonetheless, as a 
presumably inherent property of any time series, compound symmetry (also known as 
sphericty) is also likely to be violated (Pinheiro & Bates, 2000, p.228), which is 
commonly dealt with by application of degrees of freedom correction techniques (e.g., 
Greenhouse & Geisser, 1959; Huynh & Feldt, 1976). Due to the inherent conceptual 
difference, however, both classes of countermeasures (i.e., appropriate model specification 
and data adjustment), shall be addressed separately within this thesis. Therefore, the 
present chapter is mostly concerned with how to adjust data by transformation techniques 
to reduce bias in simple GLM approaches. Model specification issues by contrast, are 
discussed in chapter 6. 
In order to illustrate the utility of the proposed data preparation techniques, this chapter 
also includes a recently published example of research (see section 5.4; Miller, Wankerl, 
Stalder, Kirschbaum, & Alexander, 2012) on cortisol stress reactivity and its moderation 
by a genetic polymorphism being found in the promoter region of the serotonin transporter 
gene SLC6A4. While the most interesting finding of this meta-analysis, namely the small 
contribution of isolated genetic variations to accounting for variance of a potential 
endophenotype for affective disorders (i.e., HPA reactivity to acute psychosocial stress), 
shall not be in the primary focus of this section, the meta-analysis shall serve to illustrate 
data preparation methods being applied prior to the calculation of effect measures to 
quantify cortisol reactivity, which in turn were submitted to a GLM-based analysis. 
Although individual study results were largely replicated by the calculation of effects from 
transformed SCC values, some borderline effect sizes (i.e., those effect size, that would 
have exhibited at least marginal significance), were substantially less obvious when 
reported in the respective original articles. Thus, a narrative review of all analyzed 
findings would have yielded a much more ambiguous result, unless data preparation 
techniques had been taken into account. 
5.2 The impact of HPA phase shift on SCC distributions 
5.2.1 Introduction 
Salivary cortisol concentrations that have been obtained in temporal proximity to HPA-
activity-inducing events, often fail to entail a normal distribution. Although such non-
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normality could be at least partly traced back to the measurement procedure, one may 
further hypothesize that the HPA axis itself might contribute to this issue due to its self-
maintaining characteristic and interindividually shifted activity phases. In the simplest 
case, the source of this phase shift is related to an individual predisposition to respond to 
the circadian day-night cycle, and consequently lead to varying times of awakening 
(Kudielka, Federenko, Hellhammer, & Wüst, 2006a). As the event of awakening has been 
consistently found to induce HPA activity, which is mirrored by the cortisol awakening 
response (CAR; Fries et al., 2009), all subsequent episode of HPA activity are thought to 
depend on this first episode (in absence of any further pacemakers like the experience of 
acute stress). The dependence of cortisol trajectories on the time of awakening is 
exemplarily illustrated for three subjects in Figure 10.  
 
Figure 10. Three exemplary cortisol trajectories, being identified by identical pulse amplitudes, phase 
duration and cortisol kinetics. Only the initial point of the trajectories (indicating awakening times; 
7:00, 7:48, and 8:24, respectively) was randomly sampled from a normal distribution. The underlying 
model did not incorporate any circadian variation of the steady-state cortisol concentration (dashed 
lines).   
Proceeding from this reasoning, and given the nonlinear hormone kinetics being outlined 
in section 2.2, the distribution of awakening time is supposed to be crucial for the 
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determining shape of cortisol concentrations that have been obtained at any certain point 
in time during the day. In order to investigate the influence of awakening time on the 
distributional shape of SCCs, a generic HPA activity pattern needs to be formalized by 
specification of an appropriate model. In order to simplify the complex dynamics of HPA 
activity, most presumably redundant sources of SCC variation (including circadian 
amplitude oscillations and randomly occurring HPA-activity-inducing events), were 
removed. Thus the pharmacokinetic model for repeated oral administration of 
pharmaceutics being introduced in section 3.3.1 was considered to be appropriate for the 
modeling of repeatedly occurring cortisol pulses and thus conditional HPA activity across 
the whole day.  
5.2.2 Simulation 
R 2.15.1 statistical software (R Core Team, 2012) served to perform all simulations and 
analyses. All model parameters, which had been estimated from the TSST-G data reported 
by (Dawans et al., 2011; see section 3.3.1), were used for simulation of oscillatory HPA 
activity: The phase duration (φ = 79 min; cf. Veldhuis et al., 1989), dose/volume of 
distribution constant (C = 26.06), cortisol absorption (ka = 0.083), and cortisol elimination 
(kel = 0.026) were assumed to be interindividually invariant, also implying presence of a 
steady-state of HPA activity across time. The only interindividually varying parameter 
time of awakening was randomly drawn for each of 1000 case in three scenarios, which 
were implemented as three different normal distributions. These three time of awakening 
distributions comprised a mean at 8 AM and a standard deviations of 30 min [N(8, 0.5)], 
45 min [N(8, 0.75)], and 60 min [N(8, 1)], respectively. 
5.2.3 Results and discussion 
After awakening of all virtual participants (the latest time of awakening was 10:46 in the 
N(8,1) scenario), the distribution properties of SCCs continued to change in an oscillatory 
manner, yielding a slight overall skewness but a strong platykurtic shape. Unsurprisingly, 
the phases of these oscillations seemed to depend on the phase duration of the underlying 
model. More interestingly, however, amplitude and phases of the oscillations were also 
modulated by the distribution of the time of awakening that initiated fluctuations of the 
time series. Figure 11 illustrates this substantial dependence of the SCC distribution 
properties on the much earlier occurring zeitgeber (e.g., the sunrise), which changes as the 
interindividual variation of awakening time becomes larger. 
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Figure 11. Progression of SCC distribution properties (skewness and kurtosis) across time. Data was 
obtained from three Monte Carlo simulations (3 scenarios: 1000 cases, each), which were based on a 
pharmacokinetic model for repeated cortisol pulses (phase duration: φ = 79 min). In each scenario, 
time of awakening was randomly drawn from different normal distributions (red data – N(8, 0.5), 
green data – N(8, 0.75), blue data – N(8, 1)). 
Regarding the whole shape of SCC distributions, another interesting pattern emerged: 
While in the SCC distribution in the N(8, 0.5) scenario the above mentioned oscillations 
indicated a pronounced transition of the modus from the smallest SCC to the largest SCC 
and vice versa (i.e., individual SCC trajectories were quite synchronized), the distribution 
seemed to converge towards a distribution equilibrium the more the awakening time 
varied between individuals. This phenomenon is depicted in Figure 12, and suggests that 
the onset of acute HPA activity between subjects needs to be scattered across the whole 
time interval between two adjacent secretory events (i.e., the phase of HPA activity) in 
order to create an equilibrated SCC distribution.  
As the HPA axis (in a real world setting) is not only responsive to awakening, but also to 
other stressful events that one may encounter during day, HPA phases might actually be 
randomly shifted between individuals, so that baseline SCC distributions are actually in an 
equilibrated state. However, the large density of high SCCs was inconsistent with to 
empirical SCC distributions (see appendix A3). This was presumably due to the simplified 
model, which incorporated a fixed upper boundary for SCCs, as well as due to 
misinformation of the model: As has been already mentioned earlier, data sets that have 
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been obtained after stress induction entail a faster elimination rate than one would expect 
on the basis of pharmacokinetic cortisol studies (see section 3.3.1). This causes the HPA 
phase durations to become shorter, and in consequence to cause a substantially larger 
fraction of subjects to display high SCCs. SCC distributions that have been systematically 
manipulated by experimental interventions (e.g., by simultaneous stress exposure), on the 
other hand, seem to behave quite similar to the oscillating bimodal SCC distributions, that 
were found in the N(8, 0.5) scenario.  
 
Figure 12. Plots of estimated SCC kernel densities at 12:30 (solid lines) and 13:15 (dashed lines) for 
two time of awakening scenarios. In both scenarios mean time of awakening was set to 8 AM, but 
standard deviations varied: The left panel shows a scenario assuming a standard deviation of 30 min 
(i.e., 95.5% of all cases awake between 7 and 9 AM), whereas the right panel shows a scenario 
assuming a standard deviation of 60 min. 
Despite of the oversimplified formalization of HPA activity in the utilized model and the 
resulting failure to completely recover the commonly reported distributions of SCC, the 
present simulation may serve to support the hypothesis that not only SCC measurement 
but also the HPA activity phase shift between individuals is likely to contribute to the 
frequently encountered violation of normality in SCCs. This needs to be considered in 
order to select appropriate statistical methods for SCC analyses. 
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5.3 Data transformation of cross-sectional and longitudinal SCCs 
5.3.1 Introduction 
Statistical analyses of endocrine data by utilization of parametric models based on the 
general linear model (GLM), for example, conventional analyses of variance (ANOVAs), 
require several assumptions in order to reliably infer on the presence of hypothesized 
effects (Harwell et al., 1992; Sakia, 1992). Among these, homoscedasticity and normality 
of models’ residuals are of particular importance when analyzing endocrine time series. 
First of all, any manifestation of an endocrine signal is subject to heteroscedasticity, that 
is, an overproportional increase of variance with growing hormone concentrations, which 
is likely to be caused by inherent properties of biochemical measurement tools (Miller et 
al., 2013). Second, hormone distributions at specific sampling points have repeatedly been 
shown to violate normality (e.g., Hanson, Maas, Meijman, & Godaert, 2000; Mueller et 
al., 2011). The inherently non-normal distribution pattern of hormone concentrations 
across time is assumed to result from the complex non-linear dynamics of secretory pulses 
and hormone elimination (Brown et al., 2001). 
These shortcomings in meeting the assumptions of GLM-based analysis led to the 
development of sophisticated computational procedures, for example, the deconvolution 
analysis (Veldhuis, 1997), which are preferable as compared to GLM-based analyses but 
entail other design complications (e.g., require more extensive and frequent sampling than 
feasible in psychophysiological studies). Thus, the utilization of basic non-parametric 
methods would offer a compromise, as they are robust to the presence of non-normality 
and heteroscedasticity. However, they are less powerful as compared to parametric 
methods. 
In order to circumvent these issues, and consequently to generate endocrine variables that 
allow application of GLM-based analyses, many researchers have dealt with 
heteroscedasticity and non-normality in a rather data-driven way by applying variance 
stabilizing and normalizing transformations (e.g., Hanson et al., 2000; Mueller et al., 
2011; Plessow, Kiesel, & Kirschbaum, 2012a). The log-transformation, in particular, 
represents a popular account, but the currently observable inconsistent application of 
transformations points towards a lack of consensus on what technique is to be considered 
as appropriate. 
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Therefore, with the present report, we intend to resolve some ambiguity on the “right” 
transformation technique for endocrine time series by systematically evaluating which 
transformation most effectively reduces heteroscedasticity and, at the same time, generates 
endocrine variables that are likely to follow Gaussian (normal) distributions. For this, we 
applied power transformations of the Box-Cox family (Box & Cox, 1964; Sakia, 1992) to 
salivary cortisol concentrations being longitudinally sampled before and after induction of 
psychosocial stress with the Trier Social Stress Test (TSST; Kirschbaum et al., 1993). 
Such cortisol data are particularly suitable for demonstrating the outlined transformation 
approach, as they feature the typical characteristics of endocrine time series, that is, 
pulsatile change and continuous elimination of hormones (Brown et al., 2001). Thus, it 
enables to check for systematically occurring shifts of hormonal concentrations’ 
distributional properties at baseline (i.e., hypothalamus-pituitary-adrenal [HPA] axis 
activity prior to stress induction), which result from interindividually varying, randomly 
occurring pulsatile oscillations, towards systematically altered hormonal distributions 
being subject to a substantial fraction of simultaneously elicited secretory pulses (to 
investigate HPA axis reactivity across time). 
5.3.2 Methods 
5.3.2.1 Sample 
Salivary cortisol data from previously published (Mueller et al., 2011; Plessow, Fischer, 
Kirschbaum, & Goschke, 2011; Plessow, Kiesel, & Kirschbaum, 2012a; Plessow, Schade, 
Kirschbaum, & Fischer, 2012b) and unpublished studies were merged. This data set 
comprised cortisol samples of 309 participants, which were obtained in temporal 
proximity to the TSST. More specifically, five samples were taken from each participant 
at t0 = -6 min, t1 = +16 min, t2 = +25 min, t3 = +35 min, and t4 = +45 min relative to TSST 
onset. Sample t0 is considered to reflect a random (baseline) cortisol sample within the 
diurnal cortisol course, as it would be employed in clinical practice for reference. By the 
time of saliva sampling, all participants were aged between 18 and 65 years, and had a 
body mass index below 30 kg/m2. The proportion between male and female participants 
was approximately balanced. All test sessions were conducted in the afternoon. All 
participants reported absence of smoking, no intake of HPA axis-altering medication 
(including hormonal contraceptives for females), and declared their written informed 
consent prior to testing. 
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5.3.2.2 Biochemical analyses 
Salivary cortisol was determined on site at the endocrine laboratory in Dresden, Germany, 
by utilization of a commercially available chemiluminescence immunoassay (IBL, 
Hamburg, Germany), which was conducted according to the protocols provided by the 
manufacturer. Intra- and inter-assay coefficients of variation were below 10%. Operational 
range was 0.50 to 110.40 nmol/L, implying that no measured cortisol concentration was 
below or above quantification limits. 
5.3.2.3 Statistical analyses 
Box-Cox power transformations15 being defined as X’ = (Xλ – 1)/ λ for λ ≠ 0, and X’ = 
loge(X) for λ = 0 (see Sakia, 1992), were applied to all cortisol sampling points by 
employing a series of λ-values ranging from λ = 1 (data remain untransformed) to λ = 0 
(log-transformation of data), resulting in transformed variable distributions, which were 
submitted to further analyses. Considering that most between-subject factors examined in 
psychophysiological research (e.g. sex) do not account for structural effects on hormone 
distributions, simple fixed-effects ANOVAs were employed to investigate the overall 
change of cortisol concentrations across time. In order to acquire powerful overall criteria 
to check for presence of heteroscedasticity and deviation from normality, we calculated χ2-
statistics from Breusch-Pagan (Breusch & Pagan, 1979) and Doornik-Hansen tests 
(Doornik & Hansen, 2008), respectively. The latter was furthermore complemented by 
calculation of 3rd and 4th order stochastic moments, namely, skewness and kurtosis. Back-
transformation to the natural scale (nmol/L) was performed by X = (λX’ + 1)1/λ for λ ≠ 0, 
and X = eX’ for λ = 0. All analyses were performed using R 2.15.0 statistical software (R 
Core Team, 2012).  
5.3.3 Results 
As expected, on its natural scale, salivary cortisol exhibited severe deviations from 
normality at all sampling points (see Table 6). All distributions were substantially skewed 
to the right (positive values for skewness), although the extent of skewness decreased until 
                                                
15 Speaking of Box-Cox power transformations, the authors are referring to the family of power functions 
defined by Box and Cox (1964; formula 1), but not to Box-Cox’s procedure to obtain the maximum-
likelihood estimates of a parameter λ. This family is extremely flexible as it represents a generalized 
form of the most popular transformations (i.e. inverse-, log- and root-transformations). 
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salivary cortisol peaked at t2, and re-increased afterwards. Similarly, leptokurtic shapes 
increased extensively with distance from the cortisol peak. Histograms with kernel density 
estimates are provided in the appendix A3. 
 
Figure 13. Figure 13a depicts the progression of the chosen criteria (χ2 statistics) after application of 
power transformations with coefficients ranging from 0 < λ ≤ 1 to longitudinally sampled salivary 
cortisol data. The quality of generating the desired variable characteristics for GLM-based analyses 
was tested: Breusch-Pagan tests (df = 4) were used to check for homoscedasticity, and Doornik-
Hansen tests (df = 2) were applied to check for normality at the respective sampling points ti. 
Exemplarily, CI0 and CI2 denote the ranges of λ for which a normal distribution at t0 (baseline, -6 
min) and t2 (peak, 25 min) can be assumed with a confidence of 95% (for the ranges and 
corresponding optima of λ for all cortisol sampling points ti see Figure 13b). 
The intersections of the Breusch-Pagan χ2 function and Doornik-Hansen χ2 function at t0 (λ = .15), and 
Doornik-Hansen χ2 functions being averaged across all ti (λ = .26) are considered to indicate the 
optimal tradeoffs for achieving homoscedasticity and normality when assessing single cortisol samples 
which are not subject to experimentally induced HPA axis activity and longitudinal cortisol time 
series, respectively, and therefore mark the optimum λ coefficients for routine-research application. 
Estimation of coefficients for power transformation λ yielded ambiguous results, as the 
optima to achieve appropriate skewness and kurtosis for Gaussian distributions differed 
considerably. Optima for skewness went along with slightly platykurtic distributions, 
which were most pronounced at the cortisol peak. Nonetheless, the tradeoff between both 
moments, that is, the λ comprising the minimized Doornik-Hansen χ2 (see Figure 13a), 
indicated normality for all coefficients between .06 < λ < .38 at t0 and .44 < λ < .61 at t2 
(see Figure 13b). Consequently, simple log-transformations (λ = 0) were always 
insufficient to generate normality at any sampling point.  
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Table 6. Outcomes of different transformation techniques for salivary cortisol data. The table lists 
estimated coefficients for power transformation and significance tests for the presence of non-
normality (Doornik-Hansen) and heteroscedasticity (Breusch-Pagan) after applying the respective 
transformation to the data. 
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Table 7. Descriptive evaluation of various transformation techniques. 
 cortisol t0 cortisol t1 cortisol t2 cortisol t3 cortisol t4 
Percentiles      
  2.5th 1.54 2.58 3.26 3.52 3.27 
  16.7th 3.70 5.87 7.57 6.83 5.71 
  Median 7.80 12.56 16.98 16.53 13.48 
  83.3th 14.25 23.40 29.98 27.06 22.08 
  97.5th 23.04 32.82 41.91 41.55 38.22 
Location1      
  Natural 9.17 14.23 18.64 17.90 14.84 
  Logarithm 7.22 11.62 15.24 14.66 12.12 
  Power λn 7.64 12.53 17.09 16.20 13.00 
  Power λs 7.38 11.86 15.64 14.92 12.34 
  Power λi 7.73 12.30 16.22 15.52 12.82 
Dispersion2      
  Natural [-3.37,21.70] [-2.69,31.14] [-2.18,39.46] [-2.59,38.40] [-3.07,32.75] 
  Logarithm [1.73, 30.16] [3.04, 44.42] [3.88, 59.96] [3.82, 56.16] [3.21, 45.72] 
  Power λn [1.46, 25.68] [2.42, 35.75] [2.56, 43.57] [2.66, 42.84] [2.57, 37.61] 
  Power λs [1.63, 27.90] [2.92, 41.12] [3.76, 54.89] [3.69, 51.92] [3.08, 42.58] 
  Power λi [1.39, 25.16] [2.62, 37.05] [3.43, 48.72] [3.32, 46.60] [2.73, 38.61] 
Skewness      
  Natural 1.67 1.03 0.61 0.78 1.18 
  Logarithm -0.43 -0.67 -0.87 -0.68 -0.53 
  Power λn 0.01 -0.02 -0.01 0.02 0.01 
  Power λs -0.25 -0,48 -0.69 -9.53 -0.37 
  Power λi 0.09 -0.16 -0.40 -0.27 -0.09 
Kurtosis3      
  Natural 7.65 4.38 2.99 3.51 5.07 
  Logarithm 3.08 3.61 3.74 3.11 3.05 
  Power λn 2.83 2.69 2.40 2.48 2.69 
  Power λs 2.90 3.18 3.26 2.84 2.84 
  Power λi 2.86 2.76 2.69 2.54 2.68 
Note. Natural scale of cortisol is nmol/L. Values in brackets refer to ranges. Subscript-denotations of 
listed power transform coefficients refer to the criteria, which are optimized by the respective λ in 
Table 5: n = normality, s = skedasticity, i = intersection of normality and homoscedasticity χ2-
functions. 1Location parameters of the variable distributions are presented as means that were back-
transformed to the natural scale. Values close to the median of the respective variable indicate 
successful normalization. 
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2Dispersion ranges are supposed to cover 95% of all values assuming normality (M ±	  1.96*SD) and 
were back-transformed to the natural scale. Successful normalization will result in values close to the 
2.5th and 97.5th percentile of the respective variable. 3Upon presence of a normal distribution, the 
expected value is 3. Distributions with kurtosis < 3 are referred to as platykurtic, distributions with 
kurtosis > 3 as leptokurtic. 
The assumption of homoscedasticity as indicated by non-significance of Breusch-Pagan χ2 
was violated for any λ > .31 (Figure 13a), implying that this GLM prerequisite is also not 
met upon utilization of untransformed data (λ = 1). 
To derive a compromise between λs to normalize all distributions simultaneously and λs 
to achieve homoscedasticity, we averaged Doornik-Hansen χ2 functions of all sampling 
points and estimated its point of intersection with the Breusch-Pagan χ2 function (Figure 
13a), which was found at λ = .26. Consistently, the proportion of variance explained by 
ANOVAs peaked at λ = .25 with R2 = .13. For isolated, random cortisol samples 
comparable to t0, this intersection occurs at λ = .15. The quality of all investigated 
transformations for generating the required distributional criteria is documented in Table 
7. 
5.3.4 Discussion 
The aim of this section was to evaluate various transformation techniques with regard to 
their utility for generating variables of endocrine time series that comply with the 
assumptions of the GLM and associated statistical tests. As a first important finding, the 
popular log-transformation was found to be inferior as opposed to other power 
transformations for the unbiased analysis of salivary cortisol being repeatedly sampled in 
temporal proximity to a psychosocial stressor. Likewise, untransformed cortisol 
concentrations, which are randomly sampled from a healthy population and thus subject to 
random (or - upon experimental stress exposure - systematic) pulsatile oscillations, cannot 
be considered as normally distributed, which is commonly encountered in endocrine stress 
research (e.g., Hanson et al., 2000; Mueller et al., 2011). This renders the solitary 
scientific presentation of cortisol concentrations by means and standard deviations of raw 
variables problematic, as it does not allow for sufficient inference on the data structure. 
However, the comparison of power transformations presented in this report clearly offers 
optimum solutions to maximize the probability of endocrine data meeting the criteria of 
normality and homoscedasticity: For single cortisol samples, that are not subject to 
  
 
62 Creating normality and homoscedasticity: GLM-based analyses 
experimentally induced HPA axis activity, the power transformation X’ = (X.15 – 1)/.15 is 
optimal, for cortisol time series X’ = (X.26 – 1)/.26 represents the most appropriate power 
transformation. For the latter, a fourth-root transformation 𝑋! = 𝑋! = 𝑋 .!" can serve as 
an easy-to-apply heuristic (Box & Cox, 1964; Osborne, 2010). It is important to note that 
it seems to be impossible to derive a discrete transformation generating distributions, 
which satisfy both homoscedasticity and normality (being indicated by skewness and 
kurtosis) simultaneously. As a consequence, there will always be some bias, although 
substantially reduced by application of an appropriate transformation. Homoscedasticity 
and distributional skewness should be considered as the most important for the evaluation 
of transformation quality (see Harwell et al., 1992). Alteration of kurtosis on the other 
hand has lower priority, as it biases GLM results to a smaller extent, which is particularly 
true for transformed distributions that are leptokurtic (Harwell et al., 1992). In the present 
case, this could not be achieved by mere minimization of skewness16 (cf. Handelsman, 
2002).  
The outlined approach to find the optimal coefficient λ for a power transformation was 
applied to cortisol concentrations, as these are subject to all features that are common to 
endocrine time series, that is pulsatile change and continuously occurring elimination of 
hormones (Brown et al., 2001). Consequently, this technique can be easily adapted to 
other endocrine data and has also been proven valuable for analyses of isolated (i.e., 
independently distributed) biological variables (e.g., Handelsman, 2002). As an alternative 
procedure to find an adequate power coefficient λ, the Box-Cox maximum likelihood 
approach (Box & Cox, 1964) could be applied which is easily available with pervasive 
software packages (e.g. SAS-‘proc transreg’ or R-‘car’). Furthermore, Osborne (2010) 
has provided a SPSS syntax macro. 
It is important to note, that it would be even more advantageous to derive transformations 
based on theory rather than driven by data. Unfortunately, this is barely feasible, as the 
untransformed empirical variable distributions being observed are likely to result from the 
dynamic interaction of generators, which follow well-characterized distributions (Brown 
et al., 2001). Explicit modeling of these generators could bypass this issue and shift the 
analytical focus from p value-centered predictor evaluation to a preferable holistic 
                                                
16 Notably, Osborne (2010) demonstrated that power transformations tend to reduce skewness less efficiently 
with variables comprising minima, which deviate strongly from 1. However, this issue can be addressed 
by manually anchoring data adding a constant c prior to transformation; X’ = ([X + c]λ – 1)/ λ. 
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comparison of a priori specified competing models, but would require more complex 
statistical techniques. In these terms, the previously discarded log-transformation could 
serve well due to its capability of linearizing first-order endocrine elimination processes 
(Munson & Rodbard, 1989). Similarly, heteroscedasticity could also be effectively averted 
by application of the log-transformation, which might result from a measurement error 
that grows exponentially with rising hormone concentrations (Miller et al., 2013). Yet, 
there might be other sources as, for example, interference of cross-reactive substances 
(Miller et al., 2013), which could alter the distribution pattern being observed with 
naturally scaled hormone concentrations, and thus optima for power transformations. 
Consequently, researchers are supposed to ensure that their auxiliary statistical hypotheses 
(i.e., their modeling assumptions) are supported by evaluation of the appropriateness of 
transformation techniques. 
In conclusion, our results suggest that the omission of data inspection with regard to GLM 
prerequisites may substantially threaten the validity of statistical inferences on endocrine 
processes, e.g. HPA axis reactivity, whenever analyses are based on hormone 
concentrations. Considering measurement error characteristics and the continuously 
occurring change of hormone levels across time, data transformation as proposed within 
this report seems mandatory to minimize bias. 
5.4 5-HTTLPR and cortisol stress reactivity: a meta analysis 
5.4.1 Introduction 
During the past years, a substantial amount of studies have been conducted on gene-
environment (GxE) interaction effects in the context of stress-related psychiatric disorders. 
Of the many candidate gene variants studied, a prominent example has been a prospective 
longitudinal study by Caspi and colleagues (Caspi et al., 2003),  indicating genetic 
variation in the promoter region (5-HTTLPR) of the serotonin transporter gene to 
moderate the association between life stress and depression. This 43bp insertion/deletion 
polymorphism presumably influences the transcription rate of the serotonin transporter (5-
HTT) gene with the short (S) allele being transcriptionally less efficient than the long (L) 
allele (Greenberg et al., 1999; Lesch et al., 1996), even though recent studies suggest a 
more complex mechanism to mediate long-term effects of 5-HTTLPR on serotonergic 
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neurotransmission (Ansorge, Zhou, Lira, Hen, & Gingrich, 2004; Murthy et al., 2010). 
Regardless of the precise molecular mechanism, accumulating evidence suggests an 
increased vulnerability to depression in carriers of at least one S allele with a significant 
history of aversive life events (Uher & McGuffin, 2008; 2010). Recent meta-analyses 
stimulated an active debate regarding the latter association, by either supporting (Karg, 
Burmeister, Shedden, & Sen, 2011) or providing no evidence (Munafò, Durrant, Lewis, & 
Flint, 2009; Risch et al., 2009) for significant GxE interaction. As a consequence of this 
ongoing controversy, experimental studies addressing biological quantitative traits 
underlying elevated stress sensitivity in S allele carriers become increasingly important 
(Caspi, Hariri, Holmes, Uher, & Moffitt, 2010). In particular, altered stress-induced 
activation of the hypothalamic-pituitary-adrenal (HPA) axis has been discussed as a 
potential intermediate phenotype (or ‘endophenotype’), possibly conveying an increased 
risk for depression as a function of 5-HTTLPR genotype (Flint & Munafò, 2007; Hasler, 
Drevets, Manji, & Charney, 2004). 
Consequently, several experimental studies have investigated the association between 5-
HTTLPR genotype and HPA-axis reactivity to standardized laboratory stressors in healthy 
individuals (Alexander et al., 2009; Bouma, Riese, Nederhof, Ormel, & Oldehinkel, 2010; 
Dougherty, Klein, Congdon, Canli, & Hayden, 2010; Gotlib, Joormann, Minor, & 
Hallmayer, 2008; Mueller et al., 2011; Shalev, unpub.; Verschoor & Markus, 2011a; Way 
& Taylor, 2010; Wüst et al., 2009). The biological rationale for these association studies 
derives from an extensive literature documenting the important role of serotonergic 
neurotransmission in HPA axis regulation (Fuller, 1990; Porter, Gallagher, Watson, & 
Young, 2004). As a result of the above mentioned studies, individuals carrying two copies 
of the S allele have been repeatedly shown to exhibit elevated cortisol secretion in 
response to acute psychosocial stress (Dougherty et al., 2010; Gotlib et al., 2008; Way & 
Taylor, 2010), thereby pointing to a neuroendocrine correlate of elevated stress sensitivity 
within these individuals. However, several studies could not replicate these initial findings 
(Alexander et al., 2009; Bouma et al., 2010; Shalev, unpub.; Verschoor & Markus, 2011a; 
Wüst et al., 2009) or have reported effects in the opposite direction (Mueller et al., 2011). 
Since most of these experimental studies comprised small sample sizes and effects of 
single genetic variants are inherently small (Munafò & Flint, 2004), we consider a meta-
analytic approach a significant contribution to this field of research. Based on above 
reviewed findings and their potential implications for the understanding of biological 
pathways conveying disease risk, we aimed to evaluate the association between 5-
  
 
65 Creating normality and homoscedasticity: GLM-based analyses 
HTTLPR genotype and HPA-axis reactivity to acute stress as well as the magnitude of this 
relationship by applying a meta-analytic technique. Moreover, we performed a formal 
testing for evidence of publication bias and explored potential moderating influences of 
participants’ age and sex.  
5.4.2  Methods and materials 
5.4.2.1 Search strategy and selection of studies  
Potential studies were identified via PubMed and PsycINFO databases up to October 2011 
using the search terms “stress”, “HPA-axis”, “cortisol”, “5-HTTLPR”, and “5-HTT” by 
independent reviewers (R.M. and N.A.). Bibliographies and citations of the retrieved 
studies were also reviewed. We further contacted research groups known to investigate 
associations of genetic polymorphisms with HPA-axis reactivity in order to identify 
additional studies in press, under review or relevant unpublished data. We considered all 
English-language studies published until October 2011 on the relationship between 5-
HTTLPR and HPA-axis reactivity comprising either single-sex or both male and female 
participants of any ethnic origin and age from a healthy population. We further refined this 
data set by selecting studies which met the following inclusion criteria: [a] induction of 
significant cortisol responses by means of standardized laboratory stressors, [b] 
application of a psychosocial stressor (no physiological or pharmacological challenges), 
[c] measurement of cortisol at baseline and during the experimental procedure (including 
at least a pre- and post stressor sample), and [d] assessment of salivary free cortisol 
concentrations as a reliable measure of biologically active cortisol (Ekins, 1990; Umeda et 
al., 1981). Furthermore, studies were excluded if reported data were part of a larger study 
already included in the present analysis.  
These criteria led to the exclusion of six potentially relevant studies. Specifically, we 
excluded two studies reporting data on cortisol reactivity to a physiological stressor 
(Mueller, Brocke, Fries, Lesch, & Kirschbaum, 2010) and a non-standardized naturalistic 
stressor (Verschoor & Markus, 2011b). Further, one study was excluded for the 
experimental stress protocol failed to induce significant increases in cortisol within the 
overall sample (Frigerio et al., 2009). Two studies (Armbruster et al., 2009; Mueller et al., 
2011) reported data from overlapping samples, thus only one (Mueller et al., 2011) entry 
was used for the present meta-analysis. Finally, one study (Jabbi et al., 2007) was 
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excluded as it assessed changes in total blood cortisol which does not constitute a 
comparable measure to free salivary cortisol concentrations as it comprises both bound 
and unbound fractions of circulating hormones (Ekins, 1990). This selection procedure 
reduced the final set size to N = 11 samples from 8 published studies of independent 
research groups and 1 unpublished study. 
5.4.2.2 Data extraction and preparation 
For each study, the following information was extracted: [a] bibliography: author(s), year 
of publication; [b] method: country of origin, ancestry of sample, sample size, mean age, 
male/female ratio, Hardy-Weinberg equilibrium (HWE), applied stress paradigm, and 
utilized assay; and [c] data: mean and standard deviation of baseline and peak natural log-
transformed salivary cortisol concentrations in response to the stressor separated for S/S, 
S/L and L/L individuals. 
A commonly applied meta-analytical practice is to extract or reconstruct central stochastic 
moments in order to enable the calculation of effect sizes. This procedure is feasible when 
the central moments characterize the distribution of an outcome variable sufficiently. The 
latter criterion is only met in case of normally distributed data (Wilcox & Keselman, 
2003). However, cortisol data are in most cases strongly positively skewed. Thus, we 
requested the central moments of the natural log-transformed cortisol values from the 
authors of the final study set. All researchers provided data suitable for further analyses. 
The principle outcome measures were mean and standard deviation of log-transformed 
salivary cortisol concentrations of pre-stressor (baseline) and post-stressor sampling points 
the (highest value within the obtained time series) separated by 5-HTTLPR genotypes. 
This outcome measure is considered most appropriate for the present meta-analysis, as the 
studies included significantly differed regarding the number of cortisol samples assessed 
throughout the experimental procedure.  This resulted in 2 x 32 genotype- specific 
samples being nested within the 11 selected study samples (the 32 genotype-specific 
samples result from 8 independent studies reporting data on 3 genotype groups with one of 
these studies comprising 3 different cohorts, Mueller et al., 2011, and 1 study reporting 
data on 2 genotype groups (SS and LL) because of selective recruitment, Verschoor & 
Markus, 2011a). 
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5.4.2.3 Analytical methods 
All analyses were performed using the metaphor-package (Viechtbauer, 2010) with R 
2.15.0 statistical software (R Core Team, 2012), by applying restricted maximum-
likelihood estimation. We adopted a well-established approach for meta-analysis applied 
in the field of genetic association studies (Mier, Kirsch, & Meyer-Lindenberg, 2010). A 
major problem with meta-analysis on single genetic variants is that different underlying 
genetic models have been applied for data analysis (Mier et al., 2010). Moreover, previous 
association studies have suggested dominant, co-dominant and recessive models of the 5-
HTTLPR S allele without a clear consensus (Uher & McGuffin, 2008). In order to 
overcome this problem, we compared both possible allele groups separately by 
aggregating samples according to an S recessive (model 1: SS versus SL/LL), and an S 
dominant (model 2: LL versus SS/SL) model. In addition, we further tested for a 
linear/additive association of 5-HTTLPR and cortisol stress reactivity, assuming a genetic 
dose model of the S allele. 
We initially started with random-effects meta-regression models, which assume that 
between-study variation is due to both random variation and individual study 
heterogeneity. This random effects framework is more conservative than fixed effects 
models and enables inferences on the presence of effects beyond the set of included 
studies (Cohn & Becker, 2003). All modeling procedures were applied to standardized 
mean differences scaled in standard deviations (Cohen’s d).  
(XII) 𝑑! = ∆𝑑!" = ∆ (!!",!"#$!!!",!"#)!"!",!!" 	  
(XIII) 𝜎!! = !(!!!!)!!" !!"!!!!"!! 1+ !!"!(!!!!)𝑑!"! − !!"!!(!!"!!)!!∈!! 	  
The interaction between 5-HTTLPR and cortisol reactivity was evaluated by fitting meta-
regression models to effect sizes appropriate for independent groups pre-test post-test 
designs (Morris & DeShon, 2002; Becker, 1988). Effect sizes (formula XII) and sampling 
variances (formula XIII) were calculated as presented below with k denoting study, i 
denoting each element of a set of two contrasted genotype groups Gk, and c representing 
the bias function (Hedges & Olkin, 1985). Between-study heterogeneity was evaluated 
using Cochran’s Q-tests (Hedges & Olkin, 1985).  
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Next, we aimed to explore potential moderators in case of a sufficient number of available 
studies to conduct meaningful analyses. As participants’ sex, age, and the experimental 
stress protocol are known to influence HPA-axis activity (Dickerson & Kemeny, 2004; 
Kudielka & Kirschbaum, 2005; Otte et al., 2005), these variables were incorporated as 
moderators within a mixed-effects framework. Standard errors of estimates were adjusted 
according to Knapp and Hartung (2003). 
In order to check for publication or selection bias, we constructed funnel plots of 
calculated effect sizes (Peters, Sutton, Jones, Abrams, & Rushton, 2008) and tested them 
for asymmetry by Egger’s test (Egger, Davey Smith, Schneider, & Minder, 1997). 
Sensitivity of the obtained results for bias was further tested by means of the trim-and-fill 
method (Duval & Tweedie, 2000a; 2000b). Finally, we conducted post-hoc power 
analyses via Monte Carlo simulations by sampling from multivariate normal distributions 
comprising the parameters revealed by the present meta-analysis and aggregating the 
corresponding interaction contrast statistics. 
5.4.3 Results 
5.4.3.1 Description of studies 
The characteristics of the 11 studies included in the present meta-analysis, which comprise 
a total sample of 1686 participants (S/S=355, S/L=787, L/L=544), are presented in Table 
8. All studies report 5-HTTLPR genotype frequencies that did not significantly deviate 
from Hardy-Weinberg-Equilibrium, except of one study where participants were 
selectively recruited according to 5-HTTLPR genotype (Verschoor & Markus, 2011a). All 
samples with the exception of a multi-ethnic sample (Way & Taylor, 2010) comprised 
Caucasian participants only. With two exceptions (Alexander et al., 2009; Gotlib et al., 
2008), all studies reported data on mixed-sex samples and comprised a wide age range, 
thus allowing to address sex and age as potential moderators in the present meta-analysis. 
The final column of Table 8 depicts whether the study reports a significant association 
between 5-HTTLPR and HPA-axis reactivity. 
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Table 8. Sample characteristics and outcome of all studies included in the present meta-analysis. 
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5.4.3.2 Meta-analysis 
The present meta-analysis revealed no significant differences in baseline cortisol levels as 
a function of 5-HTTLPR either when individuals were aggregated according to an S 
recessive (µ1.base = 0.04; 95% CI -0.07, 0.15; p = 0.43) or an S dominant (µ2.base = 0.03; 
95% CI -0.08, 0.14; p = 0.56) model. The random effects meta-regression model revealed 
a significant association between 5-HTTLPR and HPA-axis reactivity to acute 
psychosocial stress, however the estimated effect size was small (d = 0.27). Specifically, 
individuals homozygous for the S allele were characterized by a significantly elevated 
cortisol response as compared to carriers of at least one L allele  [µ1.resp = 0.27; 95% CI: 
0.07, 0.48; p < 0.05]. Figure 14 presents a plot of effect sizes by 5-HTTLPR genotype 
according to a recessive model of the S allele for the individual studies included in the 
present meta-analysis. 
Conversely, no significant genotype depended differences in cortisol reactivity were 
observed when individuals were aggregated according to an S dominant model [µ2.resp = 
0.07; 95% CI: -0.05, 0.18; p = 0.22]. A recessive model of the S allele was further 
supported by subsequent bivariate comparisons revealing a marginally significant higher 
cortisol reactivity in SS versus SL individuals [µSS = 0.32; 95% CI: -0.03, 0.67; p = 0.07], 
whereas no difference was observed between LL versus SL subjects [µLL = 0.03; 95% CI: 
-0.11, 0.17; p = 0.67]. In addition, we further tested whether the association between 5-
HTTLPR and cortisol reactivity is better described by a linear/additive model. Again, 
result revealed a recessive model of the S allele to provide a better fit for the present data, 
as only a marginally significant association appeared when applying a genetic dose model 
[µβ = 0.05; 95% CI: 0.00, 0.11; p = 0.06]. 
Furthermore, the present meta-analysis revealed no significant between-study 
heterogeneity regarding the interaction of 5-HTTLPR and cortisol stress reactivity [S 
recessive model: χ21.resp(10) = 10.83; p = 0.37, and S dominant model: χ22.resp(10) = 5.84; p 
= 0.83].  
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Figure 14. Forest plot of study effect sizes for the association between 5-HTTLPR genotype and 
cortisol stress reactivity assuming a recessive effect of the 5-HTTLPR S allele (95% confidence 
intervals [CI]). Dot size reflects the relative sample size of the individual study. 
5.4.3.3 Moderator Analyses 
Despite the lack of significant between-study heterogeneity, we conducted further 
analyses to check for potential moderators of the association between 5-HTTLPR and 
cortisol stress reactivity (proceeding from an S recessive model). The data set included 
allowed a meaningful moderator analysis for participants’ age, sex and the experimental 
stress protocol applied (TSST vs. other protocols). Incorporating these moderators within 
a mixed-effects framework, the meta-regression revealed none of the above mentioned 
variables to significantly account for variance across studies (Table 9). The random-
effects reference model accounted similarly well for the data as compared to all mixed-
effects moderation models (all p values > .40). 
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Table 9. Effect sizes (β) and confidence intervals (CI) of isolated and joint influences of potential 
moderators of the association between 5-HTTLPR genotype and cortisol reactivity as determined by 
four different meta-regression models. 
 Model-specific parameter properties Test of moderators 
 β t p 95% CI F p 
Isolated moderation       
(1) intercept 0.32 1.40 0.19 -0.20; 0.84 0.04 0.86 
      % male -0.08 -0.19 0.86 -1.04; 0.88   
(2) intercept 0.61 2.79 0.02 0.12; 1.11 2.66 0.14 
      mean age -0.02 -1.63 0.14 -0.04; 0.01   
(3) intercept 0.22 1.38 0.20 -0.14; 0.59 0.03 0.60 
      stressor 0.12 0.55 0.60 -0.36; 0.60   
Joint moderation       
(4) intercept 0.24 1.02 0.34 -0.32; 0.81 0.22 0.88 
      % male -0.06 -0.16 0.88 -0.88; 0.77   
      mean age -0.01 -0.66 0.53 -0.03; 0.02   
      stressor -0.04 -0.24 0.82 -0.47; 0.38   
5.4.3.4 Sensitivity analysis 
Since the decision to publish research findings as well as the study selection within a 
meta-analytical context are often subject to bias, contour enhanced funnel plots were 
constructed and tested for asymmetry (Figure 15). Neither visual inspection nor Eggers 
test [t1(9)=0.72, p = 0.49; t2(9) = -0.84, p = 0.42] suggested a severe publication or 
selection bias, which appears consistent with the outcome variability observed across the 
studies included in our meta-analysis. Nevertheless, we further applied the trim-and-fill 
method in order to account for a slight left-sided asymmetry. Imputing one study reduced 
the estimated effect size (assuming an S recessive model) to a minimal extent, but 
increased confidence for rejecting the null-hypothesis [µ1a.resp = 0.26; 95% CI: 0.09, 0.43; 
p < 0.01]. Omitting the study of Way and Taylor (2010) as their sample was of mixed 
ancestry did not change the significance of the meta-analytic outcome [µ1b.resp = 0.24; 95% 
CI: 0.04, 0.43; p < 0.05], thus highlighting the robustness of the reported results. 
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Figure 15. Contour enhanced funnel plot of study-specific effect sizes (SMD) assuming a recessive 
effect of the 5-HTTLPR S allele. The (dark-) grey areas comprise study-specific effects with 0.95 < p < 
0.99 and 0.90 < p < 0.95 (two-sided), the white area comprises all studies where no significant 
association between 5-HTTLPR genotype and cortisol stress reactivity was detected. The hollow circle 
denotes an imputed study. The dashed line represents the estimated true effect (SMD = .26). 
 
Figure 16. Conditional on the true effects size (three scenarios), left panel [A] indicates statistical 
power for detecting a significant interaction between 5-HTTLPR genotype and cortisol stress 
reactivity in a random population sample. Right panel [B] shows the same, but for a selectively 
recruited sample, comprising a balanced number of S/S and L/L carriers. 
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5.4.3.5 Statistical Power 
Monte Carlo power simulation (10000 sample draws) revealed that conditional on an 
allele frequency of approximately 60% in a predominately Caucasian population (Lesch et 
al., 1996), testing for significant interaction between 5-HTTLPR genotype and cortisol 
increase over time (baseline to peak; r = .5, d = .27) would require a sample of 
approximately 968 participants in order to achieve a power of 80% (Figure 16a). 
However, Monte Carlo power analysis revealed a substantial increase in power when 
participants were selectively recruited according to 5-HTTLPR genotype (equal number of 
S/S and L/L), thus reducing the required sample to approximately 424 participants (d = 
.27) in order to achieve a power of 80% (Figure 16b). 
5.4.4 Discussion 
The present meta-analysis revealed a significant association between 5-HTTLPR genotype 
and HPA-axis reactivity to acute psychosocial stress. Specifically, individuals 
homozygous for the S allele were characterized by an increased cortisol secretion in 
response to challenge compared to individuals with the S/L and L/L genotype. While 
visual inspection and formal testing suggested no evidence for a severe publication or 
selection bias, the possibility of a small bias still exists as Egger’s test is considered a 
week statistical method to detect such an effect in case of a small number of studies with 
similar size. Our meta-analytic results are consistent with animal research demonstrating 
exaggerated HPA-axis responses to stress in mice with targeted disruption of the serotonin 
transporter (5-HTT) gene (Li, Wichems, Heils, & Van de Kar, 1999; Tjurmina, Armando, 
Saavedra, Goldstein, & Murphy, 2002). Furthermore, the present meta-analysis 
complements the wide variety of experimental human studies documenting significant 
associations between 5-HTTLPR and intermediate processes related to stress sensitivity, 
which have been recently summarized in comprehensive reviews (Caspi et al., 2010; 
Homberg & Lesch, 2011). These findings along with the current results lend support to the 
notion that the S allele is associated with an increased sensitivity to stressful 
environmental conditions, thereby possibly conveying elevated vulnerability to psychiatric 
diseases. While recent meta-analyses provide inconsistent results regarding the latter 
assumption (Karg et al., 2011; Munafò et al., 2009; Risch et al., 2009), interindividual 
variation in HPA-axis reactivity as a function 5-HTTLPR at least hints towards a potential 
mechanism underlying this association. In line with this, altered HPA-axis reactivity has 
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been discussed as a promising endophenotype in the context of major depression (Flint & 
Munafò, 2007; Hasler et al., 2004) for it appears to be partly heritable (Federenko et al., 
2004; Kirschbaum, Wüst, Faig, & Hellhammer, 1992b), temporally stable (Cohen et al., 
2000) and has been observed in depressed patients (Holsboer, 2001; Lopez-Duran, 
Kovacs, & George, 2009; Plotsky, Owens, & Nemeroff, 1998) and their non-affected 
relatives (Holsboer, Lauer, Schreiber, & Krieg, 1995). Despite the fact that HPA-axis 
hyper-reactivity represents a correlate or even causal factor for a wide variety of physical 
and psychological diseases (Chrousos, 2009), it also has to be recognized as a fundamental 
adaptive process preparing the organism to cope with environmental challenges (McEwen, 
2007). Against this background, the question whether increased HPA-axis reactivity in S 
allele carriers constitutes either a risk or resilience factor presumably depends on the 
individuals’ specific environmental conditions and has to be differently evaluated for 
specific short- and long-term outcomes. The latter perspective supports the recently 
proposed assumption that a common genetic variant associated with disease risk is only 
maintained throughout evolution with such persistence if it holds the potential for 
compensatory beneficial effects (Homberg & Lesch, 2011).  
While extensive literature documents profound influences of serotonergic 
neurotransmission on HPA-axis regulation (Fuller, 1990; Porter et al., 2004), the precise 
mechanisms mediating the association of 5-HTTLPR and cortisol responsivity remain 
largely unexplored. Animal research implies that mechanistic pathways may go far 
beyond acute effects of 5-HTTLPR on extracellular serotonin levels, but more likely 
involve persistent alterations in neural development of cortico-limbic circuits known to 
modulate HPA-axis activity (Murphy & Lesch, 2008; Weaver et al., 2007). Furthermore, 
epigenetic modifications are considered a promising mechanism, given that serotonergic 
signaling has been shown to mediate prenatal “programming” of the developing HPA-axis 
through changes in DNA methylation patterns of HPA-axis relevant genes (Meaney, 2010; 
Weaver et al., 2007). However, exploring potential mechanisms is further complicated by 
recent imaging studies indicating that 5-HTTLPR genotype might not be associated with 
stable alterations of 5-HTT density (Murthy et al., 2010; Parsey et al., 2006) as initially 
assumed. Alternatively, S allele carriers have been suggested to show more dynamic 
changes of 5-HTT availability in response to environmental cues (Kalbitzer et al., 2010), 
implicating that gene-environment interaction might already work at the very early level 
of gene expression. Future studies are needed to elucidate the precise functional 
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consequences of 5-HTTLPR genotype to further explore neurodevelopmental and 
epigenetic mechanisms conveying stable changes of HPA-axis regulation. 
As a second major outcome, the present meta-analysis revealed that although significant, 
the effect size for the association of 5-HTTLPR and HPA-axis reactivity appeared to be 
small. This finding opposes the assumption that increased effects sizes of single genetic 
variants can be generally observed when intermediate phenotype measures such as 
endocrine response patterns are assessed compared to complex behavioral phenotypes 
(Mier et al., 2010; Munafò, Brown, & Hariri, 2008). Based on the pooled effect size 
estimates, monte carlo power analysis suggests that any given study on a random 
population sample would require at least 785 participants to achieve 80% power in order 
to detect an association between 5-HTTLPR and cortisol stress reactivity. However, such 
power can also be reached with approximately 354 participants selectively recruited 
according to 5-HTTLPR in order to allow comparison of an equal number of S/S and L/L 
subjects, which has become an increasingly common approach. In conclusion, our post 
hoc power analysis suggests that even the largest study to date (Bouma et al., 2010) was 
underpowered to detect the small effect revealed by the present meta-analysis. This further 
highlights the usefulness of meta-analytical approaches in the field of experimental 
genetic association studies which usually comprise small samples due to their time 
consuming nature. 
In contrast to our findings, a medium effect size has been reported in a meta-analysis on 
single genetic variants and amygdala reactivity to aversive stimuli (Mier et al., 2010; 
Munafò et al., 2008), indicating penetrance of genetic variants to be especially high (but 
also see: Murphy et al., 2013) for neural response patterns. Considering 
neurodevelopmental effects as potential mechanisms underlying the associations between 
5-HTTLPR and HPA-axis reactivity, it might be speculated that neural intermediate 
phenotypes are more directly linked to the individuals’ genotype, whereas cortisol release 
reflects a more “downstream” measure of stress sensitivity. Supporting this notion, several 
studies on 5-HTT knock-out mice (Ren-Patterson et al., 2005; Tjurmina et al., 2002) and 
rhesus monkeys (Barr et al., 2004) indicate that the association between altered 5-HTT 
functioning and endocrine stress reactivity appears to be more robust for 
adrenocorticotropic hormone levels, a more “upstream” measure of HPA-axis reactivity. 
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Despite the small effects size of the association between 5-HTTLPR and cortisol reactivity 
suggested by the present meta-analysis, it appears likely that stronger effects might be 
observed in specific populations or when gene-gene and gene-environment interaction is 
taken into account. While our meta-analysis revealed no evidence for moderating effects 
of  age and sex, other potential moderators could not be addressed due to the small number 
of available studies. Among them, sample ancestry has been repeatedly identified as a 
potential moderator in genetic association studies of 5-HTTLPR (Clarke, Flint, Attwood, 
& Munafò, 2010), although removal of the only multi-ethnic study (Way & Taylor, 2010) 
did not substantially alter the present meta-analytical results. Moreover, the magnitude of 
the observed association may further be modulated by other functional polymorphism 
within the 5-HTT gene (e.g. rs25531, Hu et al., 2006, or by other genetic variants which 
have been associated with altered HPA-axis activity, DeRijk, 2009). Furthermore, the 
association between 5-HTTLPR genotype and HPA-axis reactivity might be more evident 
under stressful environmental conditions, as suggested by initial studies in humans 
(Alexander et al., 2009; Mueller et al., 2011) and rhesus monkeys (Barr et al., 2004; 
McCormack, Newman, Higley, Maestripieri, & Sanchez, 2009). Against the background 
of the current discussion on GxE interaction in major depression, a meta-analytical 
evaluation of 5-HTTLPR x environmental adversity interaction on cortisol stress reactivity 
would be of great interest. Unfortunately, information on life events is only available from 
4 study samples (Alexander et al., 2009; Mueller et al., 2011) and above all has been 
obtained with different measures comprising different types of stressors, which prevents a 
meaningful analysis based on the present data set. 
When evaluating the findings of the present meta-analysis, several limitations have to be 
taken into account. First, our meta-analysis is based on a relatively small number of data 
sets from a limited number of research groups. Second, the question whether the strength 
of the association between 5-HTTLPR and cortisol stress responses varies across different 
age groups, as it has been suggested by initial findings (Mueller et al., 2011), should be re-
evaluated once more data becomes available from specific age groups, who are 
underrepresented in the current data set (especially children and older adults). In 
conclusion, the present study is the first to provide a meta-analytical evaluation of the 
association between 5-HTTLPR genotype and HPA-axis reactivity to acute psychosocial 
stress and thus contributes to the current debate on potential mechanisms mediating 
vulnerability for the development of psychiatric disorders as a function of 5-HTTLPR 
genotype. 
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6. Relaxing sphericity: moment structure analyses 
6.1 Overview 
As introduced in section 3.3, moment (i.e., mean and covariance) structure analyses can 
serve to extend the well-known GLM framework, by specification of additional auxiliary 
hypotheses, which serve to account for complete data structures in stress research. While 
direct specification of moment structures is feasible, at least in theory, physiologically 
plausible specification of moment structures can quickly become quite complex. This 
applies in particular, when the fitting of data to a model requires that varying time 
intervals between the collection of specimens are to be taken into account (e.g., by 
specification of spatial covariance structures; Bonate, 2011), which is often encountered in 
stress research. Fortunately, most modern statistical packages provide the opportunity to 
indirectly specify moment structures by reliance on path notation. This notation can serve 
to split essential parts of a moment structure model into smaller elements that relate to 
each other. For instance, a simple regression model, which relates some i subjects’ 
SCCi(t0) to their SCCs at some other point in time SCCi(t1), can be split into three 
components: 
a) one path to map the mean of SCC(t1);     SCCi(t1) = β0 
b) one path to map the variation in SCC(t0) onto SCC(t1);   SCCi(t1) = β1*SCCi(t0) 
c) one path to map the residual variation in SCC(t1);  SCCi(t1) = εi  
All three components are additive (i.e., independent from each other) and contribute to 
accounting for the complete moment structure of SCCi(t1) = β0 + β1*SCCi(t0) + εi. This 
corresponds to the autoregressive approach being outlined in section 3.3.1. In order to 
enable an appropriate understanding of moment structure analyses, and thus to 
demonstrate its flexibility and associated opportunities for stress research in the present 
chapter, the concept of path notation shall be outlined within a more popular framework, 
that is, the discrete-time GLM (ANOVAs). In the end, the flexibility of the outlined path 
notation shall be used to develop and illustrate generic structural equation models (SEM) 
that incorporate knowledge about time series of SCCs, which contain the HPA activity 
parameters that researches actually seek to assess. 
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Figure 17. Path diagrams visualizing the moment structures of two different discrete-time models. 
Rectangles denote manifest (observable) variables. Ellipses denote latent variables. The triangle is 
used to map the models’ mean structures. Panel A shows a conventional fixed-effects regression of 
cortisol levels on two points in time (t0 and t1). Panel B shows the same model, but uses multivariate 
parametrization. Such a model is called a latent trajectory or latent growth curve model. 
Let’s assume a researcher samples two saliva specimens per participant in order to assess 
HPA activity at baseline (t0) and peaking SCCs after simultaneous HPA stimulation in all 
participants (t1). The researcher intends to assess if SCCs change significantly from t0 to 
t1, by fitting a simple linear regression using sampling time as a predictor. A path diagram 
of this univariate regression model cortisol = β1*time + β0 is depicted in Figure 17a. The 
coefficient β1 denotes the regression slope, from which the ΔSCC could be calculated 
given the time variable and the regression intercept β0 (i.e., the mean SCC at t0 in case 
time(t0) = 0). Such a model would form a special case of continuous-time modeling, in 
which one assumes that the change is constant for all participants per time unit. As this 
assumption is quite unrealistic (see chapter 3.3.1), one could switch the perspective to 
discrete-time modeling by dummy coding of the time variable (i.e., t0 is coded 0 and t1 is 
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coded 1) and only interpreting the absolute change that occurs from t0 to t1. This specific 
model corresponds to a conventional fixed-effects one-way ANOVA. 
Importantly, the same univariate model can be specified as a so-called latent trajectory (or 
growth curve) model within the structural equation framework by multivariate 
parameterization (Muthén & Muthén, 2010), that is, the criterion variable cortisol can be 
partitioned into two separate variables: cortisol at t0 and cortisol at t1. The corresponding 
path diagram is depicted in Figure 17b. Subsequently two growth factors (regression 
intercept and slope) can be estimated using both of these criterion variables as indicators, 
which fractionate the cortisol moment structure (i.e., means and (co-)variances) at the t0 
and t1. This is implemented by fixing the slope factor loadings according to the coding that 
has been previously used for the time variable in the univariate model (Figure 17a). By 
contrast, the intercept factor is formed via same loadings from cortisol at t0 and t1. As any 
mean structure of cortisol at t0 and t1 is omitted, the means of the two growth factors are 
estimated according to intercept β0 and slope β1 of the univariate model. Furthermore, this 
multivariate parameterization reveals three essential constraints that are implicitly 
incorporated into the univariate model: First, intercept and slope are identical for all 
participants (σ20 = σ21 = 0). Second, the cortisol variances ε are supposed to be constant 
across time (ε0 = ε1 = ε), that is, homoscedasticity is assumed. Third, the cortisol variances 
ε are supposed to be uncorrelated. 
Considering these constraints and knowledge about HPA physiology (chapter 2) and SCC 
measurement (chapter 4), one may however argue, that SCCs at t0 and t1 are neither 
independent from each other, nor have constant (residual) variances. Such assumption can 
be specified by modification of the model-implied covariance structure, which is 
represented by all parameters in the model’s path diagram. In the present case, by which 
the researcher intends to investigate HPA activity across only two time points t0 and t1, the 
covariance between both can be implemented by freely estimating the intercept’s variance 
(σ20 ≠ 0), that is, the SCC baseline is allowed to vary randomly between participants. Such 
a model corresponds to a mixed-effects (or repeated-measures) one-way ANOVA and 
yields a compound-symmetric (or spherical) covariance structure. Heterogeneous 
variances can be implemented similarly by estimation of SCC residuals separately for 
each time point (ε0 ≠ ε1), and many more variants are easily implementable by using the 
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path notation, as study designs become more complex and involve more sampling across 
time17. 
In order to highlight the usability of this SEM technique and its advantages for the 
quantification of HPA activity within the present chapter, section 6.2 demonstrates and 
discusses a special SEM approach that is particularly suitable for the analysis of pulsatile 
change of hormone concentrations. Then, in section 6.3, the same modeling approach is 
used to clarify an important methodological issue in stress research that relates to the 
convenient detection of salivary cortisol pulses by fixed-threshold classification criteria. 
6.2 Analysis of SCCs by autoregressive latent trajectory (ALT) modeling 
6.2.1 Introduction 
Hypotheses regarding differences in endocrine patterns between participant groups that 
systematically vary with respect to a certain variable, e.g. disease status or a treatment 
condition are frequently encountered in the field of endocrine research and commonly 
investigated by repeated-measure designs. A vast repertoire of analytical strategies for 
such repeated-measure designs has been applied to endocrine time series (Blackwell, de 
Leon, & Miller, 2006; MacCallum, Kim, Malarkey, & Kiecolt-Glaser, 1997), of which the 
univariate mixed-effects approach, in particular, repeated-measures analyses of variance 
(ANOVA) still seem to be the most popular, presumably due to familiarity and 
convenience of implementation via pervasive software packages. 
However, utilization of the ANOVA framework will come along with several 
shortcomings, if the longitudinal data, to which it is applied, does not exhibit sphericity 
(Blackwell et al., 2006), a term relating to the equality of (co-)variances across adjacent 
sampling points. Violation of sphericity is likely to occur with endocrine time series and 
will eventually result in an inflation of Type I error rate, that is, any difference between 
                                                
17 There is a large variety of possible covariance structure (e.g., autoregressive structures), which shall not be 
discussed in detail. Such covariance structures are presented by Bonate (2011) or Christensen, Johnson, 
Branscum, and Hanson (2011). Matrix notation of the presented heterogeneous compound-symmetric 
covariance structure is a follows for three sampled specimens: 
𝜎!! 𝜎!𝜎!𝜌 𝜎!𝜎!𝜌𝜎!𝜎!𝜌 𝜎!! 𝜎!𝜎!𝜌𝜎!𝜎!𝜌 𝜎!𝜎!𝜌 𝜎!!   
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factor levels is more likely to be reported as significant, although none is actually present. 
Conversely, statistical power of a significant difference would increase, if covariance 
structure assumptions were taken into account (McArdle, 2009). Apart from adjusting 
ANOVA results by various correction techniques, other mixed-effects approaches allow to 
relax the sphericity assumption by modeling the covariance structure explicitly 
(autoregressive models) and/or to treat time as a continuous rather than a nominal variable 
enabling researchers to implement a priori specified trajectory shapes of underlying 
endocrine patterns (growth curve models). Yet, all of these approaches feature a major 
issue, the measurement error, which can be quite substantial with endocrine data being 
obtained by immunoassays (Veldhuis et al., 1989). 
With the present section, a readily comprehensible and flexible statistical template is 
presented, which provides the opportunity to implicitly model assumptions regarding 
covariance and mean structure of endocrine patterns by specifying parameters that govern 
the continuous and pulsatile change of hormone concentrations over time. This change is 
supposed to be free of measurement error. In more detail, we intend to combine the 
advantages of two types of structure equation models (SEM) for the analysis of 
trajectories being estimated from time courses of cortisol concentrations in temporal 
proximity to a psychosocial stressor. The first type of SEM, we are referring to, is a 
unidirectional hidden Markov model (HMM; see McArdle, 2009), which shall be used to 
separate measurement error from systematic variance of cortisol samples. The second type 
of SEM is a so-called autoregressive latent trajectory model (ALT; Bollen & Curran, 
2004) which, in turn, can be delineated in two parts: latent change scores to depict the 
autoregressive influences of true cortisol over time (McArdle, 2009) and latent growth 
factors to map the progression of endocrine changes. 
Regarding cortisol, these growth factors are modeled according to knowledge about the 
dynamic interaction of all involved endocrine mechanisms, that is, pulsatility and 
hormonal decay (Veldhuis et al., 1989), and may furthermore render particularly valuable 
for the reliable quantification of hypothalamus-pituitary-adrenal (HPA) axis reactivity, 
which has, for example, recently gained considerable attention for serving as a potential 
endophenotype of major depression (Hasler et al., 2004). Within the proposed SEM both, 
the HMM, and the ALT parts, can be implemented by three hierarchically organized 
layers. With regard to parameter parsimony, the HMM layer might be considered as 
obsolete but is beneficial considering the magnitude of measurement error, which is 
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caused by immunoassays that are not run in duplicates (Miller et al., 2013). The ALT 
layers, however, are mandatory, as they represent the content-related core for analyses of 
endocrine time series and serve as basis for evaluating various assumptions about 
underlying processes. In contrast to previous work on SEM application to cortisol time 
series, that was not able to do so due to specification of saturated models (Willoughby, 
Vandergrift, Blair, & Granger, 2007), we will demonstrate that mere autoregressive 
influences of initial cortisol on subsequent changes will diminish, when these changes are 
conditioned on cortisol concentration at the initial time point of a series, cortisol decay, 
and magnitude of secretory episodes. 
6.2.2 Methods 
6.2.2.1 Sample 
Salivary cortisol data from previously published and unpublished studies was merged (see 
Miller & Plessow, 2013), resulting in a total sample of 309 participants. By the time of 
saliva sampling all participants were aged between 18 and 65 years and had a body mass 
index below 30 kg/m2. All participants reported absence of smoking, and no intake of 
HPA-axis altering medication (including hormonal contraceptives in case of female sex). 
6.2.2.2 Procedure 
All participants were exposed to the Trier Social Stress Test (TSST; Kirschbaum et al., 
1993), a standardized protocol to induce psychosocial stress in laboratory settings. All test 
sessions were conducted in the afternoon and comprised saliva sampling utilizing 
Salivette® sampling devices (Sarstedt, Nümbrecht, Germany) at six points of time, 
namely, t0 = -6 min, t1 = +16 min, t2 = +25 min, t3 = +35 min, t4 = +45 min, and t5 = +55 
min relative to TSST onset. 
6.2.2.3 Biochemical analyses 
Salivary cortisol was determined on site at the endocrine laboratory in Dresden, Germany, 
by utilization of a commercially available chemiluminescence immunoassay (IBL, 
Hamburg, Germany), which was conducted according to the protocols provided by the 
manufacturer. Intra-, and inter-assay coefficients of variation were below 10%.	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6.2.2.4 Statistical analyses 
All statistical analyses were performed using the lavaan-package (Rosseel, 2012) with R 
2.15.0 statistical software (R Core Team, 2012). Prior to model specification, data was 
loge-transformed in order to linearize first-order pharmacokinetics of cortisol time series 
(Munson & Rodbard, 1989), and to eliminate eventually occurring heteroscedasticity, 
which would enable us to constrain time point-specific residuals (i.e., the measurement 
errors) to equality. Subsequently, we specified several models (see appendix A4 for 
syntax) that were fitted to the data using full maximum-likelihood estimation, which 
accounted for a missing data-point fraction of 6.4%. Chi-square statistics were rescaled 
according to Yuan and Bentler (1998). Model comparisons were performed using 
likelihood-ratio tests as well as by contrasting several fit indices (i.e., comparative fit 
index (CFI), root mean square error of approximation (RMSEA), standardized root mean 
square residual (SRMR), and the Bayesian information criterion (BIC); cf. Hu & Bentler, 
1998). 
6.2.3 Results and discussion 
Descriptive statistics for all cortisol time series are provided in Table 10. A latent 
autoregression model18 served as a starting point for further investigation of cortisol 
patterns (model 1; see Figure 18a). For didactic purposes, a latent change-score 
parameterization was chosen for this basic model, which is uncommon for autoregressive 
approaches but favorable with regard to the interpretation of the growth factors that we 
intended to add in the course of further model specifications. Thus, true cortisol 
concentrations that were estimated from t1 – t5 cortisol samples, were decomposed into 
lagged influences of t0 cortisol on subsequent cortisol changes that occurred over time, 
and uncorrelated residual variances (disturbances) of these changes (McArdle, 2009). All 
autoregressions predicted significantly the respective change [ps ≤ .04]. However, the 
model yielded a poor overall fit [χ2(9) = 37.13, p < .001; CFI = .98; RMSEA = .10; SRMR 
= .04; BIC = 629.73], suggesting a substantial amount of remaining covariance across the 
disturbances. 
                                                
18 The HMM layers of the models serve for measurement of true cortisol within the present analytical design 
and shall not be considered any further (for conceptualisation see McArdle, 2009). 
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Table 10. Descriptive statistics for salivary cortisol concentrations across sampling points. 
 t0 cortisol t1 cortisol t2 cortisol t3 cortisol t4 cortisol t5 cortisol 
Moments       
  Mean 9.17 14.23 18.64 17.90 14.84 13.91 
  SD 6.40 8.63 10.62 10.46 9.14 7.95 
  Skewness 1.67 1.03 0.61 0.78 1.18 1.26 
  Kurtosis 7.65 4.38 2.99 3.51 5.07 5.25 
Percentiles       
  Minimum 0.59 0.69 0.98 1.39 1.13 3.18 
  17th centile 3.71 5.98 7.61 6.85 5.92 6.57 
  Median 7.80 12.56 16.98 16.53 13.48 12.46 
  83th centile 14.08 22.92 29.77 26.90 22.08 20.32 
  Maximum 43.96 54.82 58.32 56.04 58.50 49.75 
Correlations       
  t0 cortisol  0.82 0.64 0.59 0.58 0.47 
  t1 cortisol 0.82  0.90 0.85 0.83 0.78 
  t2 cortisol 0.65 0.89  0.95 0.92 0.89 
  t3 cortisol 0.56 0.80 0.94  0.97 0.96 
  t4 cortisol 0.50 0.74 0.86 0.95  0.99 
  t5 cortisol 0.41 0.68 0.79 0.91 0.98  
# missing 0 0 1 1 0 117 
Note. N = 309. Moments and percentiles refer to cortisol scaled in nmol/L. Correlations above the 
main diagonal of the matrix are calculated from cortisol scaled in loge(nmol/L), whereas correlations 
below the main diagonal are calculated from cortisol scaled in nmol/L. 
In order to account for more covariance, we specified another SEM (model 2), that 
incorporates knowledge about pulsatile cortisol change, which is likely to occur within 30 
to 40 min after onset of a psychosocial stressor (Dickerson & Kemeny, 2004), by freely 
estimating a growth factor (labeled “cortisol pulse”) from the (co-)variance of cortisol 
changes Δt1, Δt2, and Δt3. Furthermore, we added a second growth factor with loadings 
fixed according to the time intervals between ti sampling points, which is supposed to 
represent cortisol decay. The constancy of decay implied by this factor specification, that 
is, cortisol changes were constant but cortisol concentrations reduced proportionally to 
time, was only feasible due to log-transformation of data (Munson & Rodbard, 1989). 
Finally, mean structure was altered according to the ALT framework (Bollen & Curran, 
2004). Estimation of this model resulted in an excellent data fit [χ2(5) = 3.19, p = .67; CFI 
> .99; RMSEA ≤ .01; SRMR = .01; BIC = 590.62] with Pr(RMSEA ≤ .05) = .98, but non-
significant autoregressions between latent changes [ps ≥ .11]. 
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Figure 18. Two structural equation models (SEM) for the analysis of cortisol time series are presented 
in this figure. Cortisol concentrations as determined by a chemiluminescence immunoassay (CLIA) 
serve as indicators (denoted by rectangles) for latent cortisol at different points of time ti. These true 
cortisol concentrations are delineated by latent changes Δti and cortisol at the preceding point of time 
ti-1. Latent variables are denoted by ellipses. The triangle symbolizes the mean structure. For reasons 
of clarity indicators’ residuals and disturbances are not shown. 
Figure 18a depicts a SEM with estimated means and autoregressions of preceding cortisol 
concentrations on subsequent latent cortisol changes (model 1). In Figure 18b, model 1 is altered by 
estimating the (co-)variance of latent cortisol changes, which is conditioned on growth factors for 
pulsatile cortisol alterations due to psychosocial stress, and continuous cortisol decay. Thus 
autoregressions between the respective points of time become obsolete (dashed arrows, model 3). 
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Therefore, we decided to constrain autoregressions to zero and fitted the model again 
(model 3; see Figure 18b). Covariance between initial cortisol and decay was constrained 
to zero for the same reason, obtaining a fit that was similarly close to the data [χ2(10) = 
10.85, p = .46; CFI > .99; RMSEA ≤ .01; SRMR = .03; BIC = 566.87] with Pr(RMSEA ≤ 
.05) = .95, but superior with regard to the trade-off between likelihood and parameter 
parsimony (see BICs). Additionally, this nested model 3 did not fit the data significantly 
worse than model 2 [Δχ2(5) = 10.62, p = .06]. Consequently, model 3 is to be preferred 
regarding an adequate mapping of pulsatile and continuous cortisol change over time. 
As can be deduced from Figure 18b, the estimated cortisol stress response unfolds its 
impact on cortisol changes in an almost constant fashion during the first 25 minutes after 
onset of the stressor (Δt1 – 6 min + Δt2). With the following 10 minutes (Δt3), however, 
the stress-induced cortisol pulse exhibits almost no effect anymore (cf. Dickerson & 
Kemeny, 2004). An estimated correlation between the magnitude of pulses and initial 
cortisol levels of r = -0.47 is consistent with the law of initial values (Jamieson & Howk, 
1992), and supports, for example, the notion, that the amplitude of a secretory pulse is 
related to the temporal proximity to the preceding pulse (Veldhuis et al., 1989). Thus, 
simple individual difference scores between “baseline” and cortisol peaks are insufficient 
to infer on the presence of a pulse and cannot serve as appropriate classifiers (see 
Benjamin, 1963). Finally the mean decay parameter of -0.18 loge(nmol/L) per 10 minutes 
corresponds to a cortisol half-life in saliva of t0.5 = 38.5 min, which is consistent with 
previous findings on cortisol kinetics in saliva after stress induction (see section 3.3.1), but 
elevated as compared to cortisol elimination after pharmacological challenge (e.g., 
Perogamvros et al., 2011). 
Proceeding from the proposed SEM, equality of the underlying factor structure across 
groups or influence of covariates is thought to be evaluated (see McArdle, 2009). For 
routine research application, however, model identification must be taken into account 
prior to data sampling, which may fail upon sampling of less than five indicators during 
the time period to be investigated. Therefore, omitting the HMM measurement layer or 
implementing other parameterizations might be considered (Bollen & Curran, 2004; 
Willoughby et al., 2007) whenever extensive sampling is not feasible. In sum, the 
proposed SEM may provide a promising formulation to the study of endocrine changes 
over time. Although we only demonstrate the utility of the proposed SEM for the well-
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known phenomenon of stress-induced cortisol secretion, it can be easily adapted to any 
other time series that involves continuous and pulsatile alterations of endocrine markers. 
6.3 Cortisol pulse detection by ALT mixture modeling 
6.3.1 Introduction 
Activity of the neuroendocrine hypothalamic-pituitary-adrenal (HPA) axis, leading to the 
secretion of cortisol, is frequently assessed in psychosomatic medicine research. Here, a 
particular focus is often on the HPA reactivity to acute stimulation which has been linked 
to a wide range of mental health conditions (Burke et al., 2005; Lovallo, 2006; Morris, 
Compas, & Garber, 2012; Petrowski, Herold, Joraschky, Wittchen, & Kirschbaum, 2010). 
On a practical level, HPA reactivity is typically assessed by using repeated salivary 
cortisol sampling during exposure to a standardised laboratory stress induction protocol, 
such as the Trier Social Stress Test (TSST, Kirschbaum et al., 1993). While this overall 
experimental approach is well established, some important methodological questions 
remain to be solved. Specifically, a frequently encountered problem concerns the reliable 
detection of a minimal salivary cortisol stress response on the individual level. This is an 
important methodological prerequisite, given that researchers often strive to distinguish 
between stress ‘responders’ and ‘non-responders’ in order to describe the overall 
effectiveness of stress induction (e.g., Kirschbaum et al., 1993; Kudielka et al., 2006b; 
Smeets et al., 2012), to restrict analyses to responder groups (Het, Rohleder, Schoofs, 
Kirschbaum, & Wolf, 2009), or to use response status as an actual outcome variable (e.g., 
Petrowski et al., 2010; Stalder et al., 2013). 
A necessary requirement for the distinction between responders vs. non-responders is the 
availability of a clearly defined criterion marking a salivary cortisol stress response. Given 
that cortisol is secreted in a pulsatile fashion (Lightman et al., 2008; Young, Abelson, & 
Lightman, 2004), the establishment of such a criterion is closely linked to knowledge 
about cortisol secretory episodes. Following this line of reasoning, the most popular 
criterion to date by Kirschbaum, Wüst, and Strasburger (1992a) and Wüst and colleagues 
(2000) draws on early data showing that a typical secretory episode elevates total plasma 
cortisol levels by at least 55.2 nmol/L (Weitzman et al., 1971) and that salivary cortisol 
levels comprise 2–5% of plasma cortisol levels. Combining these data, the authors 
  
 
89 Relaxing sphericity: moment structure analyses 
reasoned that a 2.5 nmol/L salivary cortisol increase should constitute a conservative 
classification criterion for the presence of a secretory episode (Kirschbaum, Wüst, & 
Strasburger, 1992a; Wüst et al., 2000). This criterion has provided a very helpful proxy 
and has thus been widely applied in HPA-axis related research (e.g., Clow, Thorn, Evans, 
& Hucklebridge, 2004; Kudielka et al., 2006b; Petrowski et al., 2010; Rosmalen et al., 
2005; Schoofs & Wolf, 2009; Smeets et al., 2012) However, to the best of our knowledge 
it has not been directly evaluated yet. Such an evaluation seems particularly necessary 
given that the prerequisites for this criterion (i.e., the amplitude of plasma cortisol pulse 
and the plasma-to-salivary cortisol ratio) are arbitrarily defined and, more importantly, 
given that other findings question the adequacy of fixed threshold criteria, such as the 2.5 
nmol/L increase. 
Regarding the latter, arguments against fixed threshold criteria particularly relate to 
measurement variation between assays (Miller et al., 2013) and to the fact that the 
magnitude of a cortisol stress response is also related to previous or concurrent 
endogenous ultradian cortisol pulsatility. Importantly, as the size of stress-induced 
glucocorticoid pulses in humans (in contrast to rodents) is similar to those of regular 
ultradian pulses (Young et al., 2004), an observed cortisol increase following stress could 
also be due to a recent stress-unrelated ultradian pulses. Furthermore, following the law of 
initial value19 (LIV; see Jin, 1992), the absolute magnitude of a stress-induced cortisol 
increase is likely to be inversely related to the cortisol concentration before stress (i.e., the 
baseline). 
Physiologically, this may be due to the fact that salivary cortisol decays exponentially 
(i.e., a greater elimination rate at higher concentrations; Perogamvros et al., 2011; Tunn et 
al., 1992) as well as stronger negative feedback control of the HPA axis at higher baseline 
levels (cf. Huizenga et al., 1998). This assumed dependence of the stress-induced 
baseline-to-peak cortisol increase on the temporal proximity of the stress-preceding 
secretory pulse is depicted in Figure 19. This is further supported by findings showing that 
cortisol pulse amplitudes become smaller the closer a pulse is to the prior one (Veldhuis et 
al., 1989, see also Balodis, Wynne-Edwards, & Olmstead, 2010). 
                                                
19 The LIV has mostly been reported with time series of autonomic biomarkers, but it is also likely to be 
present in cortisol time series (Ramsay & Lewis, 2003). 
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Figure 19. Illustration of the relation between baseline-to-peak distance and lag between the onset 
times of two adjacent cortisol pulses. Panel A shows two adjacent cortisol pulses, whose onset times 
differ by 40 minutes. While the solid line represents a stress-preceding secretory pulse (onset: t0 – 40 
min), the dashed line indicates a stress-induced pulse (onset: t0). Both pulses are modeled having an 
identical amplitude (salivary cortisol released per pulse ≈ 10 nmol/L). Cortisol response classification 
criteria are subject to the distance d between cortisol at baseline (t0) and peak. Panel B shows the 
progression of this distance conditional on the onset time (relative to t0) of a stress-preceding cortisol 
pulse. The solid circle would mark the expected mean (± 95% of intersecretory pulse intervals), if the 
pulse at t0 was not stress-induced but by “regular” ultradian HPA activity (Veldhuis et al., 1989). 
Considering these potential shortcomings of absolute threshold criteria, the present study 
had two major objectives: First, we set out to provide a physiologically plausible, 
statistical model for cortisol stress responses using an autoregressive latent trajectory 
(ALT; Bollen & Curran, 2004) structural equation modelling framework. Second, we used 
the response classifications derived from the ALT model to evaluate the utility of several 
proposed classifier proxies that are suitable for the use in normal research routine. These 
classifiers included (a) the raw baseline-to-peak increase (rBPi; Kirschbaum, Wüst, & 
Strasburger, 1992a; Wüst et al., 2000), (b) the percentage baseline-to–peak increase 
(%BPi; e.g., Balodis et al., 2010),  and (c) the baseline-to-peak increase being calculated 
from log-transformed cortisol levels (tBPi). In addition, given the assumed dependence of 
the cortisol responsivity on baseline levels (Ramsay & Lewis, 2003), we also examined 
the utility of (d) baseline-to-peak increases adjusted for initial cortisol levels.  
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6.3.2 Methods 
6.3.2.1 Participants and data set 
Salivary cortisol data were merged from previously published (Mueller et al., 2011; 
Plessow et al., 2011; Plessow, Kiesel, & Kirschbaum, 2012a; Plessow, Schade, 
Kirschbaum, & Fischer, 2012b) and unpublished studies, resulting in data from a total 
sample of 504 healthy participants. At the time of study, all participants were aged 
between 18 and 65 years and had a body mass index below 30 kg/m2. Participants did not 
report smoking, intake of prescribed medication, or use of hormonal contraceptives (in 
females). All studies were conducted in accordance with the Declaration of Helsinki and 
approved by the local ethics committee. 
6.3.2.2 Procedure 
309 participants were exposed to the TSST (Kirschbaum et al., 1993), a well-established 
protocol to induce psychosocial stress in laboratory settings. The remaining 195 
participants completed the placebo-version of the TSST which involves a comparable 
procedure that is stripped of any stress-inducing components (Het et al., 2009). All test 
sessions were conducted in the afternoon and involved saliva sampling using Salivette® 
devices (Sarstedt, Nümbrecht, Germany). In each study, saliva was sampled at -6 min (t0), 
+16 min (t1), +25 min (t2), +35 min (t3), +45 min (t4), and +55 min (t5; planned 
missingness in one study, n = 117), relative to the onset of the TSST/placebo-TSST. 
6.3.2.3 Biochemical analyses 
Salivary cortisol was determined at the TUD Biopsychology laboratory, Dresden, using a 
commercially available chemiluminescence immunoassay (IBL, Hamburg, Germany), 
which was conducted according to the protocols provided by the manufacturer. The assay 
had an operational range between 0.50 to 110.40 nmol/L and inter- and intra-assay 
coefficients of variation were 8.4% and 4.6%, respectively. 
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6.3.2.4 Statistical analyses 
Prior to statistical modeling, data were loge-transformed in order to reduce exponential 
growth of measurement error, and to linearize first-order kinetics (i.e., the exponential 
decay of cortisol; Miller & Plessow, 2013; Munson & Rodbard, 1989). Loge-transformed 
data reasonably approximated multivariate normality of cortisol concentrations as 
indicated by chi-square quantile plots of ordered Mahalanobis distances (Cox & Small, 
1978). Due to the missing data (1.2%) that was assumed to be missing at random, we 
estimated model parameters applying full information maximum likelihood numerical 
integration. All analyses were performed using Mplus (Muthén & Muthén, 2010) and the 
ROCR-package (Sing, Sander, Beerenwinkel, & Lengauer, 2005) with R 2.15.1 statistical 
software (R Core Team, 2012). 
In the main analyses, we first set out to specify an ALT model (Bollen & Curran, 2004) 
which is depicted in Figure 20. The model ascribes mean and (co)variance structure of the 
cortisol data by three features: (i) cortisol levels at baseline (t0), (ii) amplitudes of the 
stress-induced cortisol pulses, and (iii) continuous cortisol elimination. In contrast to 
conventional growth curve models, the pulse factor loadings λ2, λ3, λ4, and λ5 were freely 
estimated in order to depict the shape of cortisol secretion adequately (latent time scaling). 
Cortisol elimination was accounted for by autoregressions βt being defined as the product 
of time lags between adjacent sampling points Δt = {2.2, 0.9, 1.0, 1.0, 1.0} and a time-
invariant autoregression parameter τ (i.e., βt = Δt * τ). Model fit was evaluated by robust 
Yuan-Bentler-scaled χ2 statistics (Yuan & Bentler, 1998) and the following fit indices (see 
Hu & Bentler, 1998): Comparative Fit Index [CFI], Root Mean Square Error of 
Approximation [RMSEA], and Square Root Mean Residual [SRMR]. 
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Figure 20. Autoregressive latent trajectory (ALT) model to separate variance components of cortisol 
time-series that are due to initial cortisol levels (variance of the manifest exogenous variable σ2t0), 
magnitude of the stress-induced cortisol pulse (growth factor variance σ2pulse), and continuous cortisol 
elimination (autoregressions βt). 
In the second step, mixture modeling (Muthen & Muthén, 2000) was implemented 
according to the hypothesis that a conceivable class of cortisol non-responders would 
exhibit a zero mean and no variance on the pulse factor (i.e., µpulse = σ2pulse = 0). 
Incremental model fit of such a two-class-solution was evaluated by utilizing the Vuong-
Lo-Mendell-Rubin likelihood ratio test (VLMR, Lo, Mendell, & Rubin, 2001), parametric 
bootstrapping (Nylund, Asparouhov, & Muthén, 2007), and the sample-size adjusted 
Bayesian information criterion (SABIC; see Tofighi & Enders, 2008). Furthermore, a 
multi-group analysis was conducted by entering a known-class variable experimental 
intervention to investigate if pulse amplitudes of cortisol responders would differ between 
the TSST and the placebo TSST group. Differences between mean trajectories of 
individual time-series were assessed by mixed-effects ANOVA. 
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Proceeding from the estimated model-based classification patterns, we finally constructed 
receiver operating characteristics (ROCs; see MacMillan & Creelman, 2005) for all 
change score classifiers (baseline-to-peak increases) proposed in the introduction. Hence, 
in this step, the responder/non-responder allocation based on the model was compared 
against allocation based on the individual classifiers (correct prediction, false negatives, 
false positives). In accordance with (Dickerson & Kemeny, 2004), cortisol levels at t0 and 
t2 were defined as baseline and peak levels, respectively. Classifier adjustment for baseline 
levels, which is necessary upon presence of the LIV (Benjamin, 1963; Linden et al., 
1997), was carried out by extraction of residuals from linear regression models predicting 
the respective change score by baseline levels. Optimal cut-off values for continuous 
classifiers were defined as the point that minimizes the trade-off between sensitivity and 
specificity of response classification; that is, the Youden’s index J (Le, 2006; Schisterman, 
Perkins, Liu, & Bondell, 2005). 
6.3.3 Results 
6.3.3.1 Descriptive statistics and change score adjustments 
Medians and interquartile ranges of salivary cortisol data and calculated change scores are 
reported in Table 11. Median cortisol increase from baseline (t0) to peak (t2) in the TSST 
and the placebo TSST group amounted to 8.12 nmol/L (IQR = 10.99) and -0.27 nmol/L 
(IQR = 3.76), respectively. The latter suggested that a substantial fraction of subjects in 
the placebo group showed an increase of salivary cortisol concentrations. Furthermore, 
descriptive analysis showed that all change scores, that is, the raw baseline-to-peak 
increase (rBPi), the baseline-to-peak increase being calculated from log-transformed 
cortisol data (tBPi), and the percentage baseline-to-peak increase (%BPi) exhibited 
positive skewness. Such violations of normality might indicate a mixture of distributions 
(i.e., the simultaneous presence of cortisol responses and non-responses). 
A significant inverse correlation was found between cortisol at t0 and tBPi [r = -0.31, p < 
.001] as well as %BPi [r = -0.32, p < .001]. This effect was even more pronounced when 
restricting analyses to TSST sessions [r’s ≥ -0,39, p’s < .001]. By contrast, cortisol at 
baseline (t0) was not found to be related to rBPi scores, neither across the whole sample [r 
= -0.02, p = .63] nor in TSST participants [r = 0.07, p = .25]. Thus, baseline adjustments 
were carried out only for tBPi and %BPi but not for rBPI scores. The regression models 
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used for baseline adjustments are shown in formulae 1 and 2. Adjusted change score 
variants shall be denoted as tBPia and %BPia. In both cases, cortisol levels at t0 predicted a 
highly significant amount of change score variance [F(1,501) ≥ 54.74, p’s ≤ .001, R2 ≥ 
9.85%]. 
1) 𝑡𝐵𝑃𝑖 = 0.754 − 0.031 ∗ 𝑐𝑜𝑟𝑡𝑖𝑠𝑜𝑙 𝑡 = 0 + 𝑡𝐵𝑃𝑖!	  	  
2) %𝐵𝑃𝑖 = 182.007 − 8.581 ∗ 𝑐𝑜𝑟𝑡𝑖𝑠𝑜𝑙 𝑡 = 0 +%𝐵𝑃𝑖!	  	  
6.3.3.2 Autoregressive growth (mixture) modeling 
Estimation of the generic one-class ALT model resulted in a good fit between model-
implied and empirical data [CFI = 0.99; RMSEA = 0.05, CI90% 0.02-0.08; SRMR = 0.04; 
SABIC = 556.33]. While the likelihood ratio test did not support this hypothesis [χ2(12) = 
28.40, p < .001], this was presumably due to the large sample size and/or a substantial 
fraction of participants who did not secrete cortisol in response to the respective 
experimental protocol (TSST or placebo). 
Separation of cortisol responders and non-responders by latent mixture modeling 
improved the data fit significantly as indicated by the VLMR statistic [2LR = 974.05, p < 
.05], parametric bootstrapping [p < .001], and a substantially increased model 
generalizability [SABIC = 528.31; ΔSABIC = 28.02]. Classification entropy was 0.77. 
Loadings of the cortisol pulse factor in the responder class were similar to those in the 
one-class ALT model. Factor loadings indicated a decreasing impact of the cortisol pulse 
factor from earlier to later sampling points [λ2 = 0.53, λ3 = 0.10, λ4 = -0.08, λ5= -0.09; all 
p’s < .01]. Furthermore, we observed a significant negative correlation between cortisol 
concentrations at t0 and the cortisol pulse factor [r = -0.33, p < .001]. The autoregression 
parameter, used to account for continuous cortisol elimination, indicated a significant 
decrease of cortisol levels across time [τ = .95, p < .001]. Variance coverage for t1–t5 
cortisol samples was equal or larger than R2 = 85% in both response classes. 
Introducing experimental protocol as a known-class variable yielded responder rates of 
86.7% for the TSST group and of 37.4% for the placebo TSST group. Formal testing for 
different cortisol trajectories between responders to both protocols revealed a strong 
interaction between sampling point and experimental protocol [F(5,335) = 51.07, p < 
.001], confirming that the TSST was a more effective stressor than the placebo TSST. The 
intraclass correlation of individual time series amounted to ICC = .81. Cortisol trajectories 
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of responders (separated by experimental protocol) and non-responders are depicted in 
Figure 21. 
 
Figure 21. Median cortisol trajectories of all responder and non-responder classes. 
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Table 11.	   Descriptive	   information	   for	   cortisol	   sampling	   points	   (t0	   –	   t5)	   and	   baseline-­‐to-­‐peak	  
change	  scores	  (rBPi,	  %BPi,	  tBPi). 
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Note. All values ti refer to cortisol concentrations scaled in nmol/L. pBPi scores are reported in 
percent. 
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6.3.3.3 Classifier performance 
Table	   12a shows the results of the comparison of the model-based classifications and 
response class allocation based on the proposed classifiers (rBPi, %BPi, tBPi, and tBPia). Table	  12b illustrates classifier performance for discriminating between the experimental 
intervention (TSST vs. placebo TSST). Calculation of Youden’s indices yielded optimal 
response thresholds at rBPi = 1.54 nmol/L [JrBPi = .897], %BPi = 15.47% [J%BPi = .844], 
and tBPi = 0.14 log(nmol/L) [JtBPi = .844], with JrBPi indicating a superior performance of 
rBPi scores. By contrast, the conventional rBPi = 2.5 nmol/L criterion (Wüst et al., 2000) 
resulted in worse performance [J = .835, false negative rate = 16.5%]. Furthermore, 
classifier performance of tBPi could be raised to an extent being comparable to rBPi 
scores by adjustment for baseline cortisol levels [tBPia = -0.32, JtBPia = .898]. This was not 
the case for baseline adjustments of the %BPi, with %BPia scores showing a considerably 
worse performance [J%BPia = .762]. While the threshold values of unadjusted classifiers 
discriminated quite conservatively between responders and non-responders (i.e., low 
number of false positive classifications), the tBPia threshold classified at a low rate of false 
negatives. Figure 22 provides a visualization of the accuracy of response class allocation 
for the respective classification criteria. 
Table	  12.	  Sensitivity	  and	  specificity	  of	  all	  dichotomized	  classifiers.	  
Criterion a) Model classification b) Experimental protocol 
 Responder Non-responder TSST Placebo 
rBPi > 2.5 nmol/L     
  Yes 284 (83.5%) 0 (0%) 248 (80.5%) 36 (19.5%) 
  No 56 (16.5%) 163 (100%) 60 (19.5%) 159 (81.5%) 
rBPi > 1.5 nmol/L     
  Yes 307 (90.3%) 1 (0.6%) 257 (83.4%) 51 (26.2%) 
  No 33 (9.7%) 162 (99.4%) 51 (16.6%) 144 (73.8%) 
%BPi > 15.5 %     
  Yes 309 (91.4%) 11 (6.7%) 264 (85.7%) 56 (28.7%) 
  No 31 (8.6%) 152 (93.3%) 44 (14.3%) 139 (71.3%) 
tBPi > 0.14 log(nmol/L)     
  Yes 310 (92.0%) 11 (6.7%) 264 (85.7%) 57 (29.2%) 
  No 30 (8.0%) 152 (93.3%) 44 (14.3%) 138 (70.8%) 
tBPia > -0.32 
log(nmol/L) 
    
  Yes 320 (97.9%) 9 (5.5%) 266 (86.4%) 63 (32.3%) 
  No 20 (2.1%) 154 (94.5%) 42 (13.6%) 132 (67.7%) 
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Note. For reasons of clarity, false positive and false negative classifications are indicated by italic font. 
 
Figure 22. Accuracy of response class allocation based on the proposed classifiers plotted against the 
chosen classifier threshold. White circles mark classifier thresholds with best performance according 
to Youden’s indices. The solid circle marks the deprecated classification criterion of rBPi = 2.5 nmol/L 
(Kirschbaum, Wüst, & Strasburger, 1992a; Wüst et al., 2000). 
6.3.4 Discussion 
The present report set out to provide a physiologically plausible statistical model for 
cortisol stress responses as basis for the evaluation of different threshold classifier proxies 
used to detect a salivary cortisol pulse. Our results indicate that the commonly applied 2.5 
nmol/L criterion (Kirschbaum, Wüst, & Strasburger, 1992a; Wüst et al., 2000) is overly 
conservative and results in a high rate of 16.5% false negative classifications (i.e., 
responders being classified as non-responders). By contrast, lowering this threshold to a 
baseline-to-peak increase of 1.5 nmol/L results in a considerable reduction of false 
negative classifications to 9.7% while maintaining virtually no false positives. Other 
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examined classifiers also showed improved performance and may also provide useful 
proxies depending on the respective research context. 
Using the calculation of Youlden’s indices, the present results indicate that optimal 
threshold levels for the examined classifiers were seen at baseline-to-peak increases of 1.5 
nmol/L for raw data, 0.14 (nmol/L) for log-transformed data, an increase of 15.5% from 
baseline or a threshold of -0.32 for the baseline-adjusted increase calculated from log-
transformed data (Benjamin, 1963; Linden et al., 1997). Overall, each of these classifiers 
performed better in distinguishing between model-assigned responders versus non-
responders than the commonly used 2.5 nmol/L criterion (Kirschbaum, Wüst, & 
Strasburger, 1992a; Wüst et al., 2000). Of these classifiers, the simplest 1.5 nmol/L 
criterion provided the most conservative results with only 0.6% false positive- but 9.7% 
false negative classifications. Conversely, the more complex baseline-adjusted log-
transformed criterion yielded a somewhat higher false positive rate of 5.5% but an 
excellent rate of only 2.1% false negative classifications. Performance of the unadjusted 
log-transformed- and the percentage increase criterion fell in between these two 
classifiers. Interestingly, all examined criteria yielded quite similar results with regard to 
discrimination between experimental protocols (approximately 20% false classifications), 
which was due to a substantial fraction of non-responders to the TSST, and responders to 
the placebo TSST. 
In evaluating the practical merit of these examined classifiers it is important to consider 
additional factors besides a maximal reduction of false classifications. Specifically, 
regarding the use of fixed threshold criteria (i.e., all examined classifiers except for the 
percentage increase), it is crucial to consider that the quantification of absolute salivary 
cortisol concentrations shows up to 250% variability depending on the assay used in 
laboratory analyses (Miller et al., 2013). Hence, the absolute threshold values provided in 
this report need to be adjusted according to knowledge about conversion parameters 
between different assays. The present 1.5 nmol/L criterion is based on salivary cortisol 
data determined by the IBL chemiluminescence immunoassay. This translates into 
approximately 0.6 nmol/L if a mass spectrometric method would be used, 1 nmol/L for the 
Salimetrics immunoassay, or 0.85 nmol/L for the DELFIA immunoassay (see Miller et al., 
2013). This dependence of fixed threshold values on the analytical technique may restrict 
the utility of these classifiers if less common commercial- or in-house assays are 
employed for which no conversion formulae are available. Here, the percentage baseline-
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to-peak increase might serve as a convenient alternative classifier, which does not rely on 
knowledge about conversion functions between assays20.  
Another interesting aspect of the current findings concerns the dependence of increase 
measures on baseline values (i.e., the LIV; e.g., Ramsay & Lewis, 2003) which was found 
to be present in the log-transformed and percentage, but not in the raw baseline-to-peak 
increase. Importantly, this reported LIV was completely driven by the way of change 
score calculation, and should be accounted for whenever statistical analyses are based on 
such scores. The failure of raw increase scores to display the expected LIV could be 
related to the fact that experiments were conducted in the afternoon where the frequency 
naturally occurring ultradian cortisol pulses is relatively low. This may have resulted in a 
relatively low variance of baseline concentrations and thus reduced power to detect 
influences on stress-induced cortisol secretion. Furthermore, it is likely that at some 
occasions the ultradian- and stress-induced secretory episodes overlapped (i.e., the steep 
rise of raw baseline-to-peak increase scores in Figure 19b, cf. Windle, Wood, Shanks, 
Lightman, & Ingram, 1998) which would mask any linear LIV effect. Consistent with this 
reasoning, we observed a significantly lower mean increase of cortisol levels in response 
to the placebo stressor we administered. 
A potential limitation of the present research relates to the fact that the evaluation of all 
classification thresholds relied on the validity of the fitted ALT mixture model. However, 
the validity of this model is supported by two strands of evidence: First, from a statistical 
perspective, model validity is indicated by high fractions of variance coverage across all 
sampling points. Second, physiological validity arises from its structure: In contrast to 
previous research trying to model cortisol secretion in response to stress by growth curve 
modelling (Schlotz, Hammerfald, Ehlert, & Gaab, 2011; Willoughby et al., 2007), our 
model embeds kinetic properties of cortisol more adequately and in a more parsimonious 
way. Specifically, the need for an explicit incorporation of two presumably redundant 
growth factors depicting overall baseline cortisol and cortisol regulation which has been 
used by previous research (Schlotz et al., 2011; Willoughby et al., 2007) is bypassed 
                                                
20 As interesting observation, the estimated percentage baseline-to-peak threshold of 15.5% would mark the 
upper bound of the 95% confidence interval of measurement, given the reported inter-assay CV of 
approximately 8%. This finding neatly adds to methodological research, that has also considered 
measurement variation as a criterion for pulse detection in endocrine time series (Van Cauter, 1988). 
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through the use of a change score parametrization (see Bollen & Curran, 2004)21. This is 
consistent with approaches considering the HPA axis to be a dynamic endocrine system 
that is subject to continuous elimination, and occasionally occurring secretory episodes 
(Brown et al., 2001). Therefore, distinct cortisol measurements of many subjects at any 
timepoint tn do not depict hormone levels at a (conditional) interindividually varying 
baseline, but rather (conditional) “resting-state” HPA activity across the whole sample. As 
such, it is not surprising, that our ALT mixture model detected cortisol pulses in 37.4% of 
all participants, who were supposed to encounter a non-stressful intervention (i.e. the 
placebo TSST; Het et al., 2009), during the time period (t0-t3) that was most relevant for 
modelling of stress-induced pulses (cf. Veldhuis et al., 1989; mean intersecretory pulse 
interval = 77 minutes). Proceeding from this reasoning, it is crucial to consider that stress-
induced HPA activity cannot be separated from regular ultradian HPA activity by 
utilization of any classifier (Young et al., 2004). Thus, even less effective stressors might 
exhibit some (mean) systematic rise of cortisol concentrations after stress cessation, which 
is only partially due to actual stress-related increase and may impose restrictions on 
statistical power to detect any functional effects of stress.  
Given the challenges associated with the reliable detection of cortisol pulses, one could 
argue that researchers interested in comparing cortisol stress responding between different 
groups may completely omit a ‘responder vs. non-responder’ distinction and solely rely on 
the assessment of group mean hormone concentrations. However, here it is important to 
note that the result of elevated group mean stress responses may arise from either (i) an 
increased magnitude of cortisol secretion or, alternatively, from (ii) an increased number 
of responders compared to non-responders. For example, it is conceivable that two groups 
may show identical mean cortisol profiles (even though with different variances), but that 
for one group these stem from a small number of individuals showing extreme stress 
responses (while the remaining individuals do not respond at all) whereas for the other 
group all individuals respond consistently at a moderate level. For many research 
questions in the areas psychosomatic medicine or psychoneuroendocrinology, it may be 
crucial to obtain such fine-grained distinctions between profiles. For this, we believe that 
the present statistical model or classifier proxies may provide an improved approach, 
                                                
21 One feature of ALT modeling is to predict the residual variance of any point in time tn by the residual 
variance of its precursor tn-1. As change scores are calculated by Δt = tn – tn-1, such an autoregression 
equation tn = β * tn-1 can be rearranged to Δt = (β-1) * tn-1, which corresponds to a common change score 
regression (McArdle, 2009). 
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which can be implemented more conveniently as compared to previously proposed 
methods to detect secretory episodes (e.g., Johnson & Veldhuis, 1995; Munson & 
Rodbard, 1989; Veldhuis & Johnson, 1986). 
In conclusion, variants of change score-based classifiers, particularly the 1.5 nmol/L raw 
baseline-to-peak increase criterion, have been shown to serve as easily applicable and 
relatively accurate proxies to detect cortisol pulses in experimental designs commonly 
used in psychophysiological stress research. Nonetheless any of these classifiers can only 
serve as a convenient heuristic. More adequate class allocation could be performed by 
statistical modeling. In these terms, the ALT mixture approach proposed in this report 
might be of value, unless sample size or the number of specimen taken per participants 
restricts its applicability. 
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7. General conclusion 
Transdisciplinary research in general, and stress research in particular, requires an 
efficient integration of methodological knowledge of all involved academic disciplines, in 
order to obtain conclusions of incremental value about the investigated constructs (cf. 
Youngblood, 2007). From a psychologist’s point of view, biochemistry and quantitative 
neuroendocrinology are of particular importance for the investigation of endocrine stress 
systems (i.e., the HPA axis, and the SNS). Despite of their fundamental role for the 
adequate assessment of endocrine activity, both topics are rarely covered by conventional 
psychological curriculae. Consequently, the transfer of the respective knowledge has to 
rely on other, less efficient channels of scientific exchange. The present thesis sets out to 
contribute to this exchange, by highlighting methodological issues that are repeatedly 
encountered in research on stress-related endocrine activity, and providing solutions to 
these issues. 
As outlined within this thesis, modern stress research tends to fall short of an adequate 
quantification of the kinetics and dynamics of bioactive cortisol. Cortisol has gained 
considerable popularity during the last decades, as its bioactive fraction is supposed to be 
reliably determinable from saliva and is therefore the most conveniently obtainable marker 
of HPA activity (Kirschbaum & Hellhammer, 1989; 2007). However, a substantial 
fraction of salivary cortisol is metabolized to its inactivated form cortisone by the enzyme 
11β-HSD2 in the parotid glands (Smith et al., 1996), which is likely to restrict its utility 
(Perogamvros et al., 2012). Although the commonly used antibody-based quantification 
methods (i.e. immunoassays) might “involuntarily” qualify this issue to some degree (due 
to their inherent cross-reactivity with matrix components that are structurally-related to 
cortisol; e.g., cortisone), they also cause differential within-immunoassay measurement 
bias (Miller et al., 2013): Salivary cortisone has (as compared to salivary cortisol) a 
substantially longer half-life (Perogamvros et al., 2011), which leads to an overestimation 
of cortisol levels the more time has passed since the onset of the prior HPA secretory 
episode, and thus tends to distort any inference on the kinetics of bioactive cortisol. 
Furthermore, absolute cortisol levels also depend on the between-immunoassay variation 
of antibodies (Miller et al., 2013). Consequently, raw signal comparisons between 
laboratories and studies, which are favorable as compared to effect comparisons, can 
hardly be performed (see Miller et al., 2012). This finding also highlights the need for the 
  
 
105 General conclusion 
long-sought standardization of biochemical measurement procedures (cf. Siest et al., 
2013). The presumably only way to circumvent both issues is to rely on quantification of 
ultrafiltrated blood cortisol by mass-spectrometric methods (Perogamvros et al., 2012).  
Being partly related to biochemical considerations with research on HPA activity, a 
second topic arises concerning the operationalization of the construct itself: In contrast to 
the simple outcome measures like averaged reaction times, inclined stress researchers can 
only indirectly infer on the sub-processes being involved in HPA activity from 
longitudinally sampled hormone concentrations (Veldhuis, 1997). According to the 
taxonomy of statistical modeling techniques for time series data being proposed by 
(Voelkle et al., 2012). HPA activity can be quantified either by (a) discrete-time, or by (b) 
continuous-time models. Although the former is the most popular and more convenient 
approach (as indicated by the overly frequent encounter of ANOVAs and trapezoidal 
AUC calculations in the field of psychobiological stress research; see Fekedulegn et al., 
2007), most discrete time models form rather data-driven, descriptive approaches to 
quantify HPA activity, that assume the existence of some endocrine resting-state (i.e., a 
baseline) at the first sampling point and disregard any mechanistic hormonal change 
occurring in between all following sampling points. Even if one ignores the fact, that such 
properties are unlikely to pertain to endocrine systems in general, many generic discrete 
time models fail to account for the specific structure of endocrine data that results from 
biochemical hormone measurement, as well as from the dynamics of the investigated 
system. More precisely speaking, cortisol time series violate homoscedasticity, residual 
normality, and sphericity, which need to be present in order to enable (mixed effects) 
GLM-based analyses. Neglecting these prerequisites may lead to inference bias unless 
counter-measures are taken (Sakia, 1992). 
Such counter-measures usually involve alteration of the scale of hormone concentrations 
via transformation techniques. As such, a fourth-root transformation of salivary cortisol 
(being determined by a widely used, commercially available immunoassay) is shown to 
yield the optimal tradeoff for generating homoscedasticity and residual normality 
simultaneously (Miller & Plessow, 2013). Although the violation of sphericity could be 
partly accounted for by several correction techniques (e.g., Greenhouse & Geisser, 1959), 
many modern software packages for structural equation modeling (e.g., Mplus, OpenMX, 
Lavaan) also offer the opportunity to easily specify more appropriate moment structures 
  
 
106 General conclusion 
via path notation and therefore to relax the modeling assumptions of GLM approaches to 
the analysis of longitudinal hormone data.  
Proceeding from this reasoning, this thesis illustrates how one can additionally incorporate 
hypotheses about HPA functioning, and thus model all relevant sub-processes that give 
rise to HPA kinetics and dynamics. The ALT modeling framework (Bollen & Curran, 
2004) being advocated within this thesis, is shown to serve well for this purpose: ALT 
modeling can recover HPA activity parameters, which are directly interpretable within a 
physiological framework, that is, distinct growth factors representing the amount of 
secreted cortisol and velocity of cortisol elimination can serve to interpret HPA reactivity 
and regulation (Linden et al., 1997) in a more unambiguous way, as compared to GLM 
effect measures. For illustration of these advantages on a content level, cortisol 
elimination after stress induction was found to be elevated as compared to its known 
pharmacokinetics. While the mechanism behind this effect requires further investigation, 
its detection would obviously have been more difficult upon application of conventional 
GLM methods. Further extension of the ALT framework allowed to address a 
methodological question, which had previously been dealt with by a mere rule of thumb; 
what’s the optimal threshold criterion, that enables a convenient but comparably accurate 
classification of individuals whose HPA axis is or is not activated upon encountering a 
stressful situation? While a rather arbitrarily chosen baseline-to-peak threshold of 2.5 
nmol/L was commonly used to identify episodes of secretory HPA activity in time series 
of salivary cortisol concentrations (c.f., Wüst et al., 2000), a reanalysis of a TSST meta-
dataset by means of ALT mixture modeling suggested that this 2.5 nmol/L criterion is 
overly conservative with modern biochemical measurement tools and should be lowered 
according to the precision of the utilized assay (i.e., 1.5 nmol/L). 
In sum, parametric ALT modeling of endocrine activity can provide a convenient 
alternative to the commonly utilized GLM-based approaches that enables the inference on 
and quantification of distinct HPA components on a theoretical foundation, and thus to 
bridge the gap between discrete- and continuous-time modeling frameworks. The 
implementation of the outlined modeling approaches by the respective statistical syntaxes 
and practical guidelines being derived from the comparison of cortisol assays mentioned 
above, are provided in the appendix of the present thesis, which will hopefully help stress 
researchers to directly quantify the construct they actually intend to assess. 
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A1. R/JAGS syntax and trace plots of Bayesian parameter estimation 
#R syntax file 
 
library(rjags) 
forJags <- list("N" = 8, "time" = c(0,12,20,30,40,50,65,80), 
"concentration" = c(7,11.5,17.5,19,16.5,13.5,10,7) ) #TSST-G data 
param <- c('Kel','Ka','sigma','const','t0','Phase') #Parameters 
modBayes <- jags.model(file="1Cm_model.bug",param, data=forJags, 
n.adapt=5000, n.chains=2) 
out <- coda.samples(modBayes, 100000, thin=10) 
summary(out) 
plot(out) 
 
#JAGS model file “1Cm_model.bug” 
 
#1 Compartment Pharmacokinetic model, 1st order absorption and 
elimination, multiple dosage 
model{ 
 concentration[1] ~ dnorm(mu[1],tau) 
mu[1] <- (const*Ka)/(Ka-Kel) * (exp(-Kel*(Phase-t0))*mEL - 
exp(-Ka*(Phase-t0))*mAB) 
 
for(i in 2:N){ 
concentration[i] ~ dnorm(mu[i],tau) 
mu[i] <- (const*Ka)/(Ka-Kel) * (exp(-Kel*(time[i]-
t0))*mEL - exp(-Ka*(time[i]-t0))*mAB) 
} 
   
   #priors 
const ~ dunif(.001,300) 
Kel ~ dunif(.001,.035) 
Ka ~ dunif(.035,.12) 
tau ~ dunif(.001,50) #Precision calculated from SD 
sigma <- sqrt(1/tau) #Gamma uninformative for SD 
t0 ~ dunif(2,11) 
Phase  ~ dunif(70,100) 
No <- 100 
mEL <- (1-exp(-No*Kel*Phase))/(1-exp(-Kel*Phase)) 
mAB <- (1-exp(-No*Ka*Phase))/(1-exp(-Ka*Phase)) 
} 
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A2. Conversion functions to predict true cortisol from measured SCCs 
LC-MS/MS (R2 = 1): Cortisol = 1.0409 *100  *LC-MS/MS 
IBL (R2 > .99):  Cortisol = 3.0702 *10-1  *IBL 
     + 8.8455 *10-3 *IBL2 
     - 4.4790 *10-4 *IBL3 
     + 1.4438 *10-5 *IBL4 
     - 1.1876 *10-7 *IBL5 
DRG (R2 > .99):  Cortisol = 4.5015 *10-1  *DRG 
     - 1.0806 *10-2 *DRG2 
     + 7.7718 *10-4 *DRG3 
     - 1.0904 *10-5 *DRG4 
     + 4.3303 *10-8 *DRG5 
DSL (R2 > .99):  Cortisol = 8.0910 *10-2  *DSL 
     + 7.8609 *10-3 *DSL2 
     - 2.6349 *10-4 *DSL3 
     + 3.7247 *10-6 *DSL4 
     - 1.5342 *10-8 *DSL5 
Salimetrics (R2 > .99): Cortisol = 5.4655 *10-1  *Salimetrics 
     - 1.4283 *10-2 *Salimetrics2 
     + 2.5661 *10-3 *Salimetrics3 
     - 6.5349 *10-5 *Salimetrics4 
     + 4.7133 *10-7 *Salimetrics5 
DELFIA(R2 > .99): Cortisol = 6.5262 *10-1 *DELFIA 
     + 1.0357 *10-3 *DELFIA2 
     + 5.5783 *10-4 *DELFIA3 
     - 1.2546 *10-5 *DELFIA4 
     + 7.5920 *10-8 *DELFIA5  
  
 
136 Appendix 
A3. Histograms and kernel density estimates of SCCs 
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A4. Exemplary R syntax for fitting an ALT model to cortisol time series 
#INITIALIZE LIBRARY AND DATA 
library(lavaan) 
setwd("path") 
rawdata <- read.csv2("data.csv") 
 
#DEFINE AUTOREGRESSIVE LATENT TRAJECTORY MODEL (MODEL 3) 
mod <- '  
##COVARIANCE STRUCTURE 
#HIDDEN MARKOV MEASUREMENT (HMM) LAYER 
cort_t0 =~ lambda*CLIA_t0 
cort_t1 =~ lambda*CLIA_t1 
cort_t2 =~ lambda*CLIA_t2 
cort_t3 =~ lambda*CLIA_t3 
cort_t4 =~ lambda*CLIA_t4 
cort_t5 =~ lambda*CLIA_t5 
 
cort_t1 ~ 1*cort_t0 
cort_t2 ~ 1*cort_t1 
cort_t3 ~ 1*cort_t2 
cort_t4 ~ 1*cort_t3 
cort_t5 ~ 1*cort_t4 
 
CLIA_t0 ~~ epsilon*CLIA_t0 
CLIA_t1 ~~ epsilon*CLIA_t1 
CLIA_t2 ~~ epsilon*CLIA_t2 
CLIA_t3 ~~ epsilon*CLIA_t3 
CLIA_t4 ~~ epsilon*CLIA_t4 
CLIA_t5 ~~ epsilon*CLIA_t5 
 
#AUTOREGRESSIVE LATENT CHANGE SCORES LAYER 
delta_t1 =~ 1*cort_t1 
delta_t2 =~ 1*cort_t2 
delta_t3 =~ 1*cort_t3 
delta_t4 =~ 1*cort_t4 
delta_t5 =~ 1*cort_t5 
 
delta_t1 ~ 0*cort_t0 
delta_t2 ~ 0*cort_t1 
delta_t3 ~ 0*cort_t2 
delta_t4 ~ 0*cort_t3 
delta_t5 ~ 0*cort_t4 
 
delta_t1 ~~ xi1*delta_t1+ 0*delta_t2+ 0*delta_t3+ 
0*delta_t4+ 0*delta_t5 
delta_t2 ~~ xi2*delta_t2+ 0*delta_t3+ 0*delta_t4+ 0*delta_t5 
delta_t3 ~~ xi3*delta_t3+ 0*delta_t4+ delta_t5 
  
 
138 Appendix 
delta_t4 ~~ xi4*delta_t4+ 0*delta_t5 
delta_t5 ~~ xi5*delta_t5 
 
#GROWTH FACTOR LAYER 
initial =~ 1*cort_t0 
pulse =~ delta_t1+ delta_t2+ delta_t3 
decay =~ 2.2*delta_t1+ .9*delta_t2+ 1*delta_t3+ 1*delta_t4+ 
1*delta_t5 
decay ~~ 0*initial 
 
##MEAN STRUCTURE 
initial ~ 1 
pulse ~ 1 
decay ~ 1 
CLIA_t0 ~ 0 
CLIA_t1 ~ 0 
CLIA_t2 ~ 0 
CLIA_t3 ~ 0 
CLIA_t4 ~ 0 
CLIA_t5 ~ 0 
' 
 
#FIT MODEL TO DATA 
fit_ALT <- sem(mod, estimator = "MLR", missing="fiml", 
data=log(rawdata)) 
 
#SUMMARIZE RESULTS 
summary(fit_ALT, fit.measures = T, standardize=T) 
	  	  	  	  	  	  	  
Denotations: 
lambda  –  factor loading 
xi   –  disturbance	  
epsilon  –  measurement error 
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